{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:20:09Z","timestamp":1793737209037,"version":"4.6.1"},"reference-count":359,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vascular contributions to cognitive impairment and dementia (VCID) represent a major public health challenge in the aging population, with age-related cerebromicrovascular dysfunction playing a critical role in its development. Understanding the mechanisms underlying cerebromicrovascular aging is crucial for devising strategies to mitigate this burden. Among the key hallmarks of aging, genomic instability and genetic heterogeneity have emerged as significant drivers of age-related diseases. Clonal hematopoiesis of indeterminate potential (CHIP) is a prominent manifestation of this instability, characterized by the non-malignant expansion of hematopoietic stem cell clones that harbor somatic mutations. CHIP is well-established as a contributor to atherosclerosis and cardiovascular disease through its promotion of chronic inflammation. Given that aging is also a major risk factor for cerebral small vessel disease (CSVD) and VCID, it is likely that the same aging processes driving large artery atherosclerosis in CHIP carriers also impair small vessels, including the cerebral microvasculature. While the role of CHIP in large vessel disease is well-documented, its specific contributions to cerebrovascular aging and microvascular dysfunction remain poorly understood. This review explores the potential role of CHIP in age-related cerebrovascular pathologies, with a particular focus on its contribution to CSVD. We discuss how CHIP-related mutations can promote inflammation and oxidative stress, potentially leading to endothelial dysfunction, dysregulation of cerebral blood flow (CBF), blood\u2013brain barrier (BBB) disruption, microvascular inflammation, and cerebral microhemorrhages. Given the potential implications for VCID, elucidating these mechanisms is critical for developing targeted therapies aimed at reducing the burden of cognitive decline in aging populations. This review aims to highlight the current knowledge gaps and encourage further research into the intersection of CHIP, CSVD, and cognitive aging.<\/jats:p>","DOI":"10.1007\/s11357-025-01654-1","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:42:59Z","timestamp":1744332179000},"page":"2739-2775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID)"],"prefix":"10.1007","volume":"47","author":[{"given":"Attila","family":"Kallai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5053-2828","authenticated-orcid":false,"given":"Anna","family":"Ungvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Csaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Orfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lehoczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef","family":"Harasztdombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Yabluchanskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Beny\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szappanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Sorond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"S\u00f3tonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajnalka","family":"Andrikovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Ungvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"1654_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbadis.2015.12.015","volume":"1862","author":"PB Gorelick","year":"2016","unstructured":"Gorelick PB, Counts SE, Nyenhuis D. Vascular cognitive impairment and dementia. Biochim Biophys Acta. 2016;1862:860\u20138. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.015.","journal-title":"Biochim Biophys Acta"},{"key":"1654_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","volume":"120","author":"M Dichgans","year":"2017","unstructured":"Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. 2017;120:573\u201391. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308426.","journal-title":"Circ Res"},{"key":"1654_CR3","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","volume":"73","author":"C Iadecola","year":"2019","unstructured":"Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M. Vascular cognitive impairment and dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73:3326\u201344. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.034.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/jnc.14287","volume":"144","author":"H Girouard","year":"2018","unstructured":"Girouard H, Munter LM. The many faces of vascular cognitive impairment. J Neurochem. 2018;144:509\u201312. https:\/\/doi.org\/10.1111\/jnc.14287.","journal-title":"J Neurochem"},{"key":"1654_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(03)00305-3","volume":"2","author":"JT O'Brien","year":"2003","unstructured":"O\u2019Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. Lancet Neurol. 2003;2:89\u201398. https:\/\/doi.org\/10.1016\/S1474-4422(03)00305-3.","journal-title":"Lancet Neurol"},{"key":"1654_CR6","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","volume":"4","author":"WM van der Flier","year":"2018","unstructured":"van der Flier WM, Skoog I, Schneider JA, Pantoni L, Mok V, Chen CLH, Scheltens P. Vascular cognitive impairment. Nat Rev Dis Primers. 2018;4:18003. https:\/\/doi.org\/10.1038\/nrdp.2018.3.","journal-title":"Nat Rev Dis Primers"},{"key":"1654_CR7","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.arr.2019.100916","volume":"53","author":"A Low","year":"2019","unstructured":"Low A, Mak E, Rowe JB, Markus HS, O\u2019Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res Rev. 2019;53:100916. https:\/\/doi.org\/10.1016\/j.arr.2019.100916.","journal-title":"Ageing Res Rev"},{"key":"1654_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-physiol-021119-034338","volume":"82","author":"TM De Silva","year":"2020","unstructured":"De Silva TM, Faraci FM. Contributions of aging to cerebral small vessel disease. Annu Rev Physiol. 2020;82:275\u201395. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034338.","journal-title":"Annu Rev Physiol"},{"key":"1654_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01139-7","author":"A Csiszar","year":"2024","unstructured":"Csiszar A, Ungvari A, Patai R, Gulej R, Yabluchanskiy A, Benyo Z, Kovacs I, Sotonyi P, Kirkpartrick AC, Prodan CI, Liotta EM, Zhang XA, Toth P, Tarantini S, Sorond FA, Ungvari Z. Atherosclerotic burden and cerebral small vessel disease: exploring the link through microvascular aging and cerebral microhemorrhages. Geroscience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01139-7.","journal-title":"Geroscience"},{"key":"1654_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01194-0","author":"A Nyul-Toth","year":"2024","unstructured":"Nyul-Toth A, Patai R, Csiszar A, Ungvari A, Gulej R, Mukli P, Yabluchanskiy A, Benyo Z, Sotonyi P, Prodan CI, Liotta EM, Toth P, Elahi F, Barsi P, Maurovich-Horvat P, Sorond FA, Tarantini S, Ungvari Z. Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment. Geroscience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01194-0.","journal-title":"Geroscience"},{"key":"1654_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1161\/STROKEAHA.122.038265","volume":"54","author":"FM Elahi","year":"2023","unstructured":"Elahi FM, Wang MM, Meschia JF. Cerebral small vessel disease-related dementia: more questions than answers. Stroke. 2023;54:648\u201360. https:\/\/doi.org\/10.1161\/STROKEAHA.122.038265.","journal-title":"Stroke"},{"key":"1654_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243\u201378. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001.","journal-title":"Cell"},{"key":"1654_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2024.1611623","author":"M Fekete","year":"2024","unstructured":"Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A. Geroscience and pathology: a new frontier in understanding age-related diseases. Pathol Oncol Res. 2024. https:\/\/doi.org\/10.3389\/pore.2024.1611623.","journal-title":"Pathol Oncol Res"},{"key":"1654_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01374-y","author":"A Kallai","year":"2024","unstructured":"Kallai A, Ungvari Z, Fekete M, Maier AB, Mikala G, Andrikovics H, Lehoczki A. Genomic instability and genetic heterogeneity in aging: insights from clonal hematopoiesis (CHIP), monoclonal gammopathy (MGUS), and monoclonal B-cell lymphocytosis (MBL). Geroscience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01374-y.","journal-title":"Geroscience"},{"key":"1654_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01113-3","author":"P Ren","year":"2024","unstructured":"Ren P, Zhang J, Vijg J. Somatic mutations in aging and disease. Geroscience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01113-3.","journal-title":"Geroscience"},{"key":"1654_CR16","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.cub.2017.07.033","volume":"27","author":"A Hernandez-Segura","year":"2017","unstructured":"Hernandez-Segura A, de Jong TV, Melov S, Guryev V, Campisi J, Demaria M. Unmasking transcriptional heterogeneity in senescent cells. Curr Biol. 2017;27:2652-2660 e2654. https:\/\/doi.org\/10.1016\/j.cub.2017.07.033.","journal-title":"Curr Biol"},{"issue":"Supplement 1","key":"1654_CR17","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1182\/blood-2021-147890","volume":"138","author":"MC Da Via","year":"2021","unstructured":"Da Via MC, Lionetti M, Matera AET, Lucca E, Riva E, Tettamanti M, Baldini L, Neri A, Della Porta MG, Bolli N. MGUS and chip: two faces, but not of the same medal. Blood. 2021;138(Supplement 1):3800. https:\/\/doi.org\/10.1182\/blood-2021-147890.","journal-title":"Blood"},{"key":"1654_CR18","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.118.034392","volume":"138","author":"P Libby","year":"2018","unstructured":"Libby P, Ebert BL. CHIP (clonal hematopoiesis of indeterminate potential): potent and newly recognized contributor to cardiovascular risk. Circulation. 2018;138:666\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034392.","journal-title":"Circulation"},{"key":"1654_CR19","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","volume":"27","author":"A Niroula","year":"2021","unstructured":"Niroula A, Sekar A, Murakami MA, Trinder M, Agrawal M, Wong WJ, Bick AG, Uddin MM, Gibson CJ, Griffin GK, Honigberg MC, Zekavat SM, Paruchuri K, Natarajan P, Ebert BL. Distinction of lymphoid and myeloid clonal hematopoiesis. Nat Med. 2021;27:1921\u20137. https:\/\/doi.org\/10.1038\/s41591-021-01521-4.","journal-title":"Nat Med"},{"key":"1654_CR20","doi-asserted-by":"publisher","first-page":"e13366","DOI":"10.1111\/acel.13366","volume":"20","author":"D Nachun","year":"2021","unstructured":"Nachun D, Lu AT, Bick AG, Natarajan P, Weinstock J, Szeto MD, Kathiresan S, Abecasis G, Taylor KD, Guo X, Tracy R, Durda P, Liu Y, Johnson C, Rich SS, Van Den Berg D, Laurie C, Blackwell T, Papanicolaou GJ, Correa A, Raffield LM, Johnson AD, Murabito J, Manson JE, Desai P, Kooperberg C, Assimes TL, Levy D, Rotter JI, Reiner AP, et al. Clonal hematopoiesis associated with epigenetic aging and clinical outcomes. Aging Cell. 2021;20:e13366. https:\/\/doi.org\/10.1111\/acel.13366.","journal-title":"Aging Cell"},{"key":"1654_CR21","doi-asserted-by":"publisher","first-page":"a035675","DOI":"10.1101\/cshperspect.a035675","volume":"10","author":"J Kaner","year":"2020","unstructured":"Kaner J, Desai P, Mencia-Trinchant N, Guzman ML, Roboz GJ, Hassane DC. Clonal hematopoiesis and premalignant diseases. Cold Spring Harb Perspect Med. 2020;10:a035675. https:\/\/doi.org\/10.1101\/cshperspect.a035675.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1654_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MOH.0000000000000675","volume":"28","author":"C Elena","year":"2021","unstructured":"Elena C, Galli A, Bono E, Todisco G, Malcovati L. Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications. Curr Opin Hematol. 2021;28:347\u201355. https:\/\/doi.org\/10.1097\/MOH.0000000000000675.","journal-title":"Curr Opin Hematol"},{"key":"1654_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s44161-023-00281-3","volume":"2","author":"W Liu","year":"2023","unstructured":"Liu W, Yalcinkaya M, Maestre IF, Olszewska M, Ampomah PB, Heimlich JB, Wang R, Vela PS, Xiao T, Bick AG, Levine R, Papapetrou EP, Libby P, Tabas I, Wang N, Tall AR. Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis. Nat Cardiovasc Res. 2023;2:572\u201386. https:\/\/doi.org\/10.1038\/s44161-023-00281-3.","journal-title":"Nat Cardiovasc Res"},{"key":"1654_CR24","doi-asserted-by":"publisher","first-page":"e180066","DOI":"10.1172\/JCI180066","volume":"134","author":"O Oren","year":"2024","unstructured":"Oren O, Small AM, Libby P. Clonal hematopoiesis and atherosclerosis. J Clin Invest. 2024;134:e180066. https:\/\/doi.org\/10.1172\/JCI180066.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"1654_CR25","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.thromres.2021.12.009","volume":"213","author":"JJ Fuster","year":"2022","unstructured":"Fuster JJ. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors. Thromb Res. 2022;213(Suppl 1):S107\u201312. https:\/\/doi.org\/10.1016\/j.thromres.2021.12.009.","journal-title":"Thromb Res"},{"key":"1654_CR26","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.jacc.2023.03.401","volume":"81","author":"ED Gumuser","year":"2023","unstructured":"Gumuser ED, Schuermans A, Cho SMJ, Sporn ZA, Uddin MM, Paruchuri K, Nakao T, Yu Z, Haidermota S, Hornsby W, Weeks LD, Niroula A, Jaiswal S, Libby P, Ebert BL, Bick AG, Natarajan P, Honigberg MC. Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2023;81:1996\u20132009. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.401.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","volume":"2","author":"SM Zekavat","year":"2023","unstructured":"Zekavat SM, Viana-Huete V, Matesanz N, Jorshery SD, Zuriaga MA, Uddin MM, Trinder M, Paruchuri K, Zorita V, Ferrer-Perez A, Amoros-Perez M, Kunderfranco P, Carriero R, Greco CM, Aroca-Crevillen A, Hidalgo A, Damrauer SM, Ballantyne CM, Niroula A, Gibson CJ, Pirruccello J, Griffin G, Ebert BL, Libby P, Fuster V, Zhao H, Ghassemi M, Natarajan P, Bick AG, Fuster JJ, Klarin D. TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease. Nat Cardiovasc Res. 2023;2:144\u201358. https:\/\/doi.org\/10.1038\/s44161-022-00206-6.","journal-title":"Nat Cardiovasc Res"},{"key":"1654_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S, Ebert BL. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1701719.","journal-title":"N Engl J Med"},{"key":"1654_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOH.0000000000000688","volume":"29","author":"I Cobo","year":"2022","unstructured":"Cobo I, Tanaka T, Glass CK, Yeang C. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease. Curr Opin Hematol. 2022;29:1\u20137. https:\/\/doi.org\/10.1097\/MOH.0000000000000688.","journal-title":"Curr Opin Hematol"},{"key":"1654_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-0716-1924-7_5","volume":"2419","author":"JB Menendez-Gonzalez","year":"2022","unstructured":"Menendez-Gonzalez JB, Rodrigues NP. Exploring the associations between clonal hematopoiesis of indeterminate potential, myeloid malignancy, and atherosclerosis. Methods Mol Biol. 2022;2419:73\u201388. https:\/\/doi.org\/10.1007\/978-1-0716-1924-7_5.","journal-title":"Methods Mol Biol"},{"key":"1654_CR31","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/s41467-022-33093-3","volume":"13","author":"MDM Uddin","year":"2022","unstructured":"Uddin MDM, Nguyen NQH, Yu B, Brody JA, Pampana A, Nakao T, Fornage M, Bressler J, Sotoodehnia N, Weinstock JS, Honigberg MC, Nachun D, Bhattacharya R, Griffin GK, Chander V, Gibbs RA, Rotter JI, Liu C, Baccarelli AA, Chasman DI, Whitsel EA, Kiel DP, Murabito JM, Boerwinkle E, Ebert BL, Jaiswal S, Floyd JS, Bick AG, Ballantyne CM, Psaty BM, et al. Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease. Nat Commun. 2022;13:5350. https:\/\/doi.org\/10.1038\/s41467-022-33093-3.","journal-title":"Nat Commun"},{"key":"1654_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jacc.2019.05.045","volume":"74","author":"SA Khetarpal","year":"2019","unstructured":"Khetarpal SA, Qamar A, Bick AG, Fuster JJ, Kathiresan S, Jaiswal S, Natarajan P. Clonal hematopoiesis of indeterminate potential reshapes age-related CVD: JACC review topic of the week. J Am Coll Cardiol. 2019;74:578\u201386. https:\/\/doi.org\/10.1016\/j.jacc.2019.05.045.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","volume":"122","author":"JJ Fuster","year":"2018","unstructured":"Fuster JJ, Walsh K. Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease. Circ Res. 2018;122:523\u201332. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312115.","journal-title":"Circ Res"},{"key":"1654_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jacc.2023.05.038","volume":"82","author":"DE Forman","year":"2023","unstructured":"Forman DE, Kuchel GA, Newman JC, Kirkland JL, Volpi E, Taffet GE, Barzilai N, Pandey A, Kitzman DW, Libby P, Ferrucci L. Impact of geroscience on therapeutic strategies for older adults with cardiovascular disease: JACC scientific statement. J Am Coll Cardiol. 2023;82:631\u201347. https:\/\/doi.org\/10.1016\/j.jacc.2023.05.038.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","volume":"53","author":"R Bhattacharya","year":"2022","unstructured":"Bhattacharya R, Zekavat SM, Haessler J, Fornage M, Raffield L, Uddin MM, Bick AG, Niroula A, Yu B, Gibson C, Griffin G, Morrison AC, Psaty BM, Longstreth WT, Bis JC, Rich SS, Rotter JI, Tracy RP, Correa A, Seshadri S, Johnson A, Collins JM, Hayden KM, Madsen TE, Ballantyne CM, Jaiswal S, Ebert BL, Kooperberg C, Manson JE, Whitsel EA, et al. Clonal hematopoiesis is associated with higher risk of stroke. Stroke. 2022;53:788\u201397. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037388.","journal-title":"Stroke"},{"key":"1654_CR36","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.123.065344","volume":"148","author":"M Yalcinkaya","year":"2023","unstructured":"Yalcinkaya M, Liu W, Thomas LA, Olszewska M, Xiao T, Abramowicz S, Papapetrou EP, Westerterp M, Wang N, Tabas I, Tall AR. BRCC3-mediated NLRP3 deubiquitylation promotes inflammasome activation and atherosclerosis in Tet2 clonal hematopoiesis. Circulation. 2023;148:1764\u201377. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065344.","journal-title":"Circulation"},{"key":"1654_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, Zuriaga MA, Yoshiyama M, Goukassian D, Cooper MA, Fuster JJ, Walsh K. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta\/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71:875\u201386. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.037.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.124.324492","volume":"135","author":"AH Polizio","year":"2024","unstructured":"Polizio AH, Marino L, Min KD, Yura Y, Rolauer L, Cochran JD, Evans MA, Park E, Doviak H, Miura-Yura E, Good ME, Wolpe AG, Grandoch M, Isakson BE, Walsh K. Experimental TET2 clonal hematopoiesis predisposes to renal hypertension through an inflammasome-mediated mechanism. Circ Res. 2024;135:933\u201350. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.324492.","journal-title":"Circ Res"},{"key":"1654_CR39","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.123.065597","volume":"149","author":"AE Lin","year":"2024","unstructured":"Lin AE, Bapat AC, Xiao L, Niroula A, Ye J, Wong WJ, Agrawal M, Farady CJ, Boettcher A, Hergott CB, McConkey M, Flores-Bringas P, Shkolnik V, Bick AG, Milan D, Natarajan P, Libby P, Ellinor PT, Ebert BL. Clonal hematopoiesis of indeterminate potential with loss of Tet2 enhances risk for atrial fibrillation through Nlrp3 inflammasome activation. Circulation. 2024;149:1419\u201334. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.065597.","journal-title":"Circulation"},{"key":"1654_CR40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1161\/CIRCULATIONAHA.122.062126","volume":"147","author":"C Vlasschaert","year":"2023","unstructured":"Vlasschaert C, Heimlich JB, Rauh MJ, Natarajan P, Bick AG. Interleukin-6 receptor polymorphism attenuates clonal hematopoiesis-mediated coronary artery disease risk among 451 180 individuals in the UK Biobank. Circulation. 2023;147:358\u201360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062126.","journal-title":"Circulation"},{"key":"1654_CR41","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","volume":"3","author":"EK Cook","year":"2019","unstructured":"Cook EK, Izukawa T, Young S, Rosen G, Jamali M, Zhang L, Johnson D, Bain E, Hilland J, Ferrone CK, Buckstein J, Francis J, Momtaz B, McNaughton AJM, Liu X, Snetsinger B, Buckstein R, Rauh MJ. Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis. Blood Adv. 2019;3:2482\u20136. https:\/\/doi.org\/10.1182\/bloodadvances.2018024729.","journal-title":"Blood Adv"},{"key":"1654_CR42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","volume":"23","author":"Z Cai","year":"2018","unstructured":"Cai Z, Kotzin JJ, Ramdas B, Chen S, Nelanuthala S, Palam LR, Pandey R, Mali RS, Liu Y, Kelley MR, Sandusky G, Mohseni M, Williams A, Henao-Mejia J, Kapur R. Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis. Cell Stem Cell. 2018;23:833-849 e835. https:\/\/doi.org\/10.1016\/j.stem.2018.10.013.","journal-title":"Cell Stem Cell"},{"key":"1654_CR43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamacardio.2020.2468","volume":"5","author":"WT Abplanalp","year":"2020","unstructured":"Abplanalp WT, Mas-Peiro S, Cremer S, John D, Dimmeler S, Zeiher AM. Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with severe degenerative aortic valve stenosis or chronic postischemic heart failure. JAMA Cardiol. 2020;5:1170\u20135. https:\/\/doi.org\/10.1001\/jamacardio.2020.2468.","journal-title":"JAMA Cardiol"},{"key":"1654_CR44","doi-asserted-by":"publisher","unstructured":"Marnell CS, Bick A, Natarajan P. Clonal hematopoiesis of indeterminate potential (CHIP): linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. 2021. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.07.004","DOI":"10.1016\/j.yjmcc.2021.07.004"},{"key":"1654_CR45","doi-asserted-by":"publisher","unstructured":"O'Carroll SJ, Kho DT, Wiltshire R, Nelson V, Rotimi O, Johnson R, Angel CE, Graham ES. Pro-inflammatory TNF\u03b1 and IL-1\u03b2 differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. 2015. https:\/\/doi.org\/10.1186\/s12974-015-0346-0","DOI":"10.1186\/s12974-015-0346-0"},{"key":"1654_CR46","doi-asserted-by":"publisher","first-page":"107255","DOI":"10.1016\/j.vph.2023.107255","volume":"154","author":"P Libby","year":"2024","unstructured":"Libby P. Inflammation and the pathogenesis of atherosclerosis. Vascul Pharmacol. 2024;154:107255. https:\/\/doi.org\/10.1016\/j.vph.2023.107255.","journal-title":"Vascul Pharmacol"},{"key":"1654_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1055\/a-2219-6410","volume":"44","author":"B Izzi","year":"2024","unstructured":"Izzi B, Fuster JJ. Clonal hematopoiesis and cardiovascular risk: atherosclerosis, thrombosis, and beyond. Hamostaseologie. 2024;44:13\u201320. https:\/\/doi.org\/10.1055\/a-2219-6410.","journal-title":"Hamostaseologie"},{"key":"1654_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s44161-021-00015-3","volume":"1","author":"AR Tall","year":"2022","unstructured":"Tall AR, Fuster JJ. Clonal hematopoiesis in cardiovascular disease and therapeutic implications. Nat Cardiovasc Res. 2022;1:116\u201324. https:\/\/doi.org\/10.1038\/s44161-021-00015-3.","journal-title":"Nat Cardiovasc Res"},{"key":"1654_CR49","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1055\/s-0041-1733856","volume":"5","author":"S Soudet","year":"2021","unstructured":"Soudet S, Jedraszak G, Evrard O, Marolleau JP, Garcon L, Pietri MAS. Is hematopoietic clonality of indetermined potential a risk factor for pulmonary embolism? TH Open. 2021;5:e338\u201342. https:\/\/doi.org\/10.1055\/s-0041-1733856.","journal-title":"TH Open"},{"key":"1654_CR50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1182\/blood-2017-07-746453","volume":"131","author":"LI Shlush","year":"2018","unstructured":"Shlush LI. Age-related clonal hematopoiesis. Blood. 2018;131:496\u2013504. https:\/\/doi.org\/10.1182\/blood-2017-07-746453.","journal-title":"Blood"},{"key":"1654_CR51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/HCO.0000000000000726","volume":"35","author":"C Jung","year":"2020","unstructured":"Jung C, Evans MA, Walsh K. Genetics of age-related clonal hematopoiesis and atherosclerotic cardiovascular disease. Curr Opin Cardiol. 2020;35:219\u201325. https:\/\/doi.org\/10.1097\/HCO.0000000000000726.","journal-title":"Curr Opin Cardiol"},{"key":"1654_CR52","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, Chavez A, Higgins JM, Moltchanov V, Kuo FC, Kluk MJ, Henderson B, Kinnunen L, Koistinen HA, Ladenvall C, Getz G, Correa A, Banahan BF, Gabriel S, Kathiresan S, Stringham HM, McCarthy MI, Boehnke M, Tuomilehto J, Haiman C, Groop L, Atzmon G, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1408617.","journal-title":"N Engl J Med"},{"key":"1654_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3324\/haematol.2018.191098","volume":"103","author":"A Condoluci","year":"2018","unstructured":"Condoluci A, Rossi D. Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis\/chronic lymphocytic leukemia: a new association? Haematologica. 2018;103:751\u20132. https:\/\/doi.org\/10.3324\/haematol.2018.191098.","journal-title":"Haematologica"},{"key":"1654_CR54","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/stem.2845","volume":"36","author":"L Busque","year":"2018","unstructured":"Busque L, Buscarlet M, Mollica L, Levine RL. Concise Review: age-related clonal hematopoiesis: stem cells tempting the devil. Stem Cells. 2018;36:1287\u201394. https:\/\/doi.org\/10.1002\/stem.2845.","journal-title":"Stem Cells"},{"key":"1654_CR55","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MOH.0000000000000465","volume":"25","author":"S Abelson","year":"2018","unstructured":"Abelson S, Wang JCY. Age-related clonal hematopoiesis: implications for hematopoietic stem cell transplantation. Curr Opin Hematol. 2018;25:441\u20135. https:\/\/doi.org\/10.1097\/MOH.0000000000000465.","journal-title":"Curr Opin Hematol"},{"key":"1654_CR56","doi-asserted-by":"publisher","first-page":"841796","DOI":"10.3389\/fragi.2022.841796","volume":"3","author":"K Walsh","year":"2022","unstructured":"Walsh K, Raghavachari N, Kerr C, Bick AG, Cummings SR, Druley T, Dunbar CE, Genovese G, Goodell MA, Jaiswal S, Maciejewski J, Natarajan P, Shindyapina AV, Shuldiner AR, Van Den Akker EB, Vijg J. Clonal hematopoiesis analyses in clinical, epidemiologic, and genetic aging studies to unravel underlying mechanisms of age-related dysfunction in humans. Front Aging. 2022;3:841796. https:\/\/doi.org\/10.3389\/fragi.2022.841796.","journal-title":"Front Aging"},{"key":"1654_CR57","doi-asserted-by":"publisher","unstructured":"Novel somatic mutations in blood driving age-related clonal hematopoiesis. Nat Genet. 2024;56:1049\u20131050. https:\/\/doi.org\/10.1038\/s41588-024-01756-0","DOI":"10.1038\/s41588-024-01756-0"},{"key":"1654_CR58","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1038\/s41467-024-52302-9","volume":"15","author":"MM Uddin","year":"2024","unstructured":"Uddin MM, Saadatagah S, Niroula A, Yu B, Hornsby WE, Ganesh S, Lannery K, Schuermans A, Honigberg MC, Bick AG, Libby P, Ebert BL, Ballantyne CM, Natarajan P. Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis. Nat Commun. 2024;15:7858. https:\/\/doi.org\/10.1038\/s41467-024-52302-9.","journal-title":"Nat Commun"},{"key":"1654_CR59","doi-asserted-by":"publisher","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S, Ebert BL. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. 2017. https:\/\/doi.org\/10.1056\/NEJMoa1701719","DOI":"10.1056\/NEJMoa1701719"},{"key":"1654_CR60","doi-asserted-by":"publisher","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. 2015. https:\/\/doi.org\/10.1182\/blood-2015-03-631747","DOI":"10.1182\/blood-2015-03-631747"},{"key":"1654_CR61","doi-asserted-by":"publisher","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, Chavez A, Higgins JM, Moltchanov V, Kuo FC, Kluk MJ, Henderson B, Kinnunen L, Koistinen HA, Ladenvall C, Getz G, Correa A, Banahan BF, Gabriel S, Kathiresan S, Stringham HM, McCarthy MI, Boehnke M, Tuomilehto J, Haiman C, Groop L, Atzmon G, Wilson JG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. 2014. https:\/\/doi.org\/10.1056\/NEJMoa1408617","DOI":"10.1056\/NEJMoa1408617"},{"key":"1654_CR62","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/blood.2019000989","volume":"136","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood. 2020;136:1606\u201314. https:\/\/doi.org\/10.1182\/blood.2019000989.","journal-title":"Blood"},{"key":"1654_CR63","doi-asserted-by":"publisher","first-page":"1281850","DOI":"10.3389\/fcell.2023.1281850","volume":"11","author":"Y Ogura","year":"2023","unstructured":"Ogura Y, Mimura I. Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease. Front Cell Dev Biol. 2023;11:1281850. https:\/\/doi.org\/10.3389\/fcell.2023.1281850.","journal-title":"Front Cell Dev Biol"},{"key":"1654_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminhematol.2024.01.012","volume":"61","author":"A Kishtagari","year":"2024","unstructured":"Kishtagari A, Corty RW, Visconte V. Clonal hematopoiesis and autoimmunity. Semin Hematol. 2024;61:3\u20138. https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.012.","journal-title":"Semin Hematol"},{"key":"1654_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jamacardio.2024.0459","volume":"9","author":"S Saadatagah","year":"2024","unstructured":"Saadatagah S, Naderian M, Uddin M, Dikilitas O, Niroula A, Schuermans A, Selvin E, Hoogeveen RC, Matsushita K, Nambi V, Yu B, Chen LY, Bick AG, Ebert BL, Honigberg MC, Li N, Shah A, Natarajan P, Kullo IJ, Ballantyne CM. Atrial fibrillation and clonal hematopoiesis in TET2 and ASXL1. JAMA Cardiol. 2024;9:497\u2013506. https:\/\/doi.org\/10.1001\/jamacardio.2024.0459.","journal-title":"JAMA Cardiol"},{"key":"1654_CR66","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/j.cell.2024.05.003","volume":"187","author":"H Wang","year":"2024","unstructured":"Wang H, Divaris K, Pan B, Li X, Lim JH, Saha G, Barovic M, Giannakou D, Korostoff JM, Bing Y, Sen S, Moss K, Wu D, Beck JD, Ballantyne CM, Natarajan P, North KE, Netea MG, Chavakis T, Hajishengallis G. Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024;187:3690-3711 e3619. https:\/\/doi.org\/10.1016\/j.cell.2024.05.003.","journal-title":"Cell"},{"key":"1654_CR67","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2337\/dc23-0805","volume":"46","author":"DK Tobias","year":"2023","unstructured":"Tobias DK, Manning AK, Wessel J, Raghavan S, Westerman KE, Bick AG, Dicorpo D, Whitsel EA, Collins J, Correa A, Cupples LA, Dupuis J, Goodarzi MO, Guo X, Howard B, Lange LA, Liu S, Raffield LM, Reiner AP, Rich SS, Taylor KD, Tinker L, Wilson JG, Wu P, Carson AP, Vasan RS, Fornage M, Psaty BM, Kooperberg C, Rotter JI, et al. Clonal hematopoiesis of indeterminate potential (CHIP) and incident type 2 diabetes risk. Diabetes Care. 2023;46:1978\u201385. https:\/\/doi.org\/10.2337\/dc23-0805.","journal-title":"Diabetes Care"},{"key":"1654_CR68","doi-asserted-by":"publisher","unstructured":"Huang AA-O, Zhou Z, Talukdar M, Miller MB, Chhouk B, Enyenihi L, Rosen I, Stronge E, Zhao BA-O, Kim D, Choi J, Khoshkhoo S, Kim JA-OX, Ganz J, Travaglini KA-O, Gabitto M, Hodge RA-O, Kaplan E, Lein E, De Jager PA-O, Bennett DA, Lee EA, Walsh CA. Somatic cancer driver mutations are enriched and associated with inflammatory states in Alzheimer\u2019s disease microglia. 2024. https:\/\/doi.org\/10.1101\/2024.01.03.574078","DOI":"10.1101\/2024.01.03.574078"},{"key":"1654_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1073\/pnas.45.1.30","volume":"45","author":"L Szilard","year":"1959","unstructured":"Szilard L. On the nature of the aging process. Proc Natl Acad Sci U S A. 1959;45:30\u201345.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1654_CR70","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"367","author":"CJ Watson","year":"2020","unstructured":"Watson CJ, Papula AL, Poon GYP, Wong WH, Young AL, Druley TE, Fisher DS, Blundell JR. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science. 2020;367:1449\u201354. https:\/\/doi.org\/10.1126\/science.aay9333.","journal-title":"Science"},{"key":"1654_CR71","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkab914","volume":"50","author":"S Sun","year":"2022","unstructured":"Sun S, Wang Y, Maslov AY, Dong X, Vijg J. SomaMutDB: a database of somatic mutations in normal human tissues. Nucleic Acids Res. 2022;50:D1100-d1108. https:\/\/doi.org\/10.1093\/nar\/gkab914.","journal-title":"Nucleic Acids Res"},{"key":"1654_CR72","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1007\/s11357-024-01113-3","volume":"46","author":"P Ren","year":"2024","unstructured":"Ren P, Zhang J, Vijg J. Somatic mutations in aging and disease. Geroscience. 2024;46:5171\u201389. https:\/\/doi.org\/10.1007\/s11357-024-01113-3.","journal-title":"Geroscience"},{"key":"1654_CR73","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1182\/blood.2019004362","volume":"135","author":"IA van Zeventer","year":"2020","unstructured":"van Zeventer IA, de Graaf AO, Wouters H, van der Reijden BA, van der Klauw MM, de Witte T, Jonker MA, Malcovati L, Jansen JH, Huls G. Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. Blood. 2020;135:1161\u201370. https:\/\/doi.org\/10.1182\/blood.2019004362.","journal-title":"Blood"},{"key":"1654_CR74","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.celrep.2018.11.014","volume":"25","author":"FG Osorio","year":"2018","unstructured":"Osorio FG, Rosendahl Huber A, Oka R, Verheul M, Patel SH, Hasaart K, de la Fonteijne L, Varela I, Camargo FD, van Boxtel R. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep. 2018;25:2308-2316.e2304. https:\/\/doi.org\/10.1016\/j.celrep.2018.11.014.","journal-title":"Cell Rep"},{"key":"1654_CR75","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, Jung H, Mitchell T, Coorens THH, Spencer DH, Machado H, Lee-Six H, Davies M, Hayler D, Fabre MA, Mahbubani K, Abascal F, Cagan A, Vassiliou GS, Baxter J, Martincorena I, Stratton MR, Kent DG, Chatterjee K, Parsy KS, Green AR, Nangalia J, Laurenti E, Campbell PJ. Clonal dynamics of haematopoiesis across the human lifespan. Nature. 2022;606:343\u201350. https:\/\/doi.org\/10.1038\/s41586-022-04786-y.","journal-title":"Nature"},{"key":"1654_CR76","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature19768","volume":"538","author":"F Blokzijl","year":"2016","unstructured":"Blokzijl F, de Ligt J, Jager M, Sasselli V, Roerink S, Sasaki N, Huch M, Boymans S, Kuijk E, Prins P, Nijman IJ, Martincorena I, Mokry M, Wiegerinck CL, Middendorp S, Sato T, Schwank G, Nieuwenhuis EE, Verstegen MM, van der Laan LJ, de Jonge J, IJzermans JN, Vries RG, van de Wetering M, Stratton MR, Clevers H, Cuppen E, van Boxtel R. Tissue-specific mutation accumulation in human adult stem cells during life. Nature. 2016;538:260\u20134. https:\/\/doi.org\/10.1038\/nature19768.","journal-title":"Nature"},{"key":"1654_CR77","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","volume":"561","author":"H Lee-Six","year":"2018","unstructured":"Lee-Six H, \u00d8bro NF, Shepherd MS, Grossmann S, Dawson K, Belmonte M, Osborne RJ, Huntly BJP, Martincorena I, Anderson E, O\u2019Neill L, Stratton MR, Laurenti E, Green AR, Kent DG, Campbell PJ. Population dynamics of normal human blood inferred from somatic mutations. Nature. 2018;561:473\u20138. https:\/\/doi.org\/10.1038\/s41586-018-0497-0.","journal-title":"Nature"},{"key":"1654_CR78","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, Wedge DC, Fullam A, Alexandrov LB, Tubio JM, Stebbings L, Menzies A, Widaa S, Stratton MR, Jones PH, Campbell PJ. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348:880\u20136. https:\/\/doi.org\/10.1126\/science.aaa6806.","journal-title":"Science"},{"key":"1654_CR79","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41586-020-1961-1","volume":"578","author":"K Yoshida","year":"2020","unstructured":"Yoshida K, Gowers KHC, Lee-Six H, Chandrasekharan DP, Coorens T, Maughan EF, Beal K, Menzies A, Millar FR, Anderson E, Clarke SE, Pennycuick A, Thakrar RM, Butler CR, Kakiuchi N, Hirano T, Hynds RE, Stratton MR, Martincorena I, Janes SM, Campbell PJ. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature. 2020;578:266\u201372. https:\/\/doi.org\/10.1038\/s41586-020-1961-1.","journal-title":"Nature"},{"key":"1654_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312\u20137. https:\/\/doi.org\/10.1038\/s41586-018-0811-x.","journal-title":"Nature"},{"key":"1654_CR81","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena I, Fowler JC, Wabik A, Lawson ARJ, Abascal F, Hall MWJ, Cagan A, Murai K, Mahbubani K, Stratton MR, Fitzgerald RC, Handford PA, Campbell PJ, Saeb-Parsy K, Jones PH. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362:911\u20137. https:\/\/doi.org\/10.1126\/science.aau3879.","journal-title":"Science"},{"key":"1654_CR82","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, Chambert K, Mick E, Neale BM, Fromer M, Purcell SM, Svantesson O, Land\u00e9n M, H\u00f6glund M, Lehmann S, Gabriel SB, Moran JL, Lander ES, Sullivan PF, Sklar P, Gr\u00f6nberg H, Hultman CM, McCarroll SA. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477\u201387. https:\/\/doi.org\/10.1056\/NEJMoa1409405.","journal-title":"N Engl J Med"},{"key":"1654_CR83","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","volume":"10","author":"T McKerrell","year":"2015","unstructured":"McKerrell T, Park N, Moreno T, Grove CS, Ponstingl H, Stephens J, Crawley C, Craig J, Scott MA, Hodkinson C, Baxter J, Rad R, Forsyth DR, Quail MA, Zeggini E, Ouwehand W, Varela I, Vassiliou GS. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep. 2015;10:1239\u201345. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.005.","journal-title":"Cell Rep"},{"key":"1654_CR84","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","volume":"130","author":"M Buscarlet","year":"2017","unstructured":"Buscarlet M, Provost S, Zada YF, Barhdadi A, Bourgoin V, L\u00e9pine G, Mollica L, Szuber N, Dub\u00e9 MP, Busque L. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood. 2017;130:753\u201362. https:\/\/doi.org\/10.1182\/blood-2017-04-777029.","journal-title":"Blood"},{"key":"1654_CR85","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, Gudjonsson SA, Gudmundsson J, Jonasson JG, Tryggvadottir L, Jonsson T, Helgason A, Gylfason A, Sulem P, Rafnar T, Thorsteinsdottir U, Gudbjartsson DF, Masson G, Kong A, Stefansson K. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood. 2017;130:742\u201352. https:\/\/doi.org\/10.1182\/blood-2017-02-769869.","journal-title":"Blood"},{"key":"1654_CR86","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","volume":"5","author":"IA van Zeventer","year":"2021","unstructured":"van Zeventer IA, Salzbrunn JB, de Graaf AO, van der Reijden BA, Boezen HM, Vonk JM, van der Harst P, Schuringa JJ, Jansen JH, Huls G. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged >\/=80 years. Blood Adv. 2021;5:2115\u201322. https:\/\/doi.org\/10.1182\/bloodadvances.2020004062.","journal-title":"Blood Adv"},{"key":"1654_CR87","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","volume":"101","author":"R Acuna-Hidalgo","year":"2017","unstructured":"Acuna-Hidalgo R, Sengul H, Steehouwer M, van de Vorst M, Vermeulen SH, Kiemeney L, Veltman JA, Gilissen C, Hoischen A. Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life. Am J Hum Genet. 2017;101:50\u201364. https:\/\/doi.org\/10.1016\/j.ajhg.2017.05.013.","journal-title":"Am J Hum Genet"},{"key":"1654_CR88","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1038\/ncomms12484","volume":"7","author":"AL Young","year":"2016","unstructured":"Young AL, Challen GA, Birmann BM, Druley TE. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun. 2016;7:12484. https:\/\/doi.org\/10.1038\/ncomms12484.","journal-title":"Nat Commun"},{"key":"1654_CR89","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41375-018-0047-7","volume":"32","author":"CM Arends","year":"2018","unstructured":"Arends CM, Galan-Sousa J, Hoyer K, Chan W, J\u00e4ger M, Yoshida K, Seemann R, Noerenberg D, Waldhueter N, Fleischer-Notter H, Christen F, Schmitt CA, D\u00f6rken B, Pelzer U, Sinn M, Zemojtel T, Ogawa S, M\u00e4rdian S, Schreiber A, Kunitz A, Kr\u00fcger U, Bullinger L, Mylonas E, Frick M, Damm F. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis. Leukemia. 2018;32:1908\u201319. https:\/\/doi.org\/10.1038\/s41375-018-0047-7.","journal-title":"Leukemia"},{"key":"1654_CR90","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","volume":"5","author":"IA van Zeventer","year":"2021","unstructured":"van Zeventer IA, Salzbrunn JB, de Graaf AO, van der Reijden BA, Boezen HM, Vonk JM, van der Harst P, Schuringa JJ, Jansen JH, Huls G. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged \u226580 years. Blood Adv. 2021;5:2115\u201322. https:\/\/doi.org\/10.1182\/bloodadvances.2020004062.","journal-title":"Blood Adv"},{"key":"1654_CR91","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41590-020-0663-z","volume":"21","author":"T Muto","year":"2020","unstructured":"Muto T, Walker CS, Choi K, Hueneman K, Smith MA, Gul Z, Garcia-Manero G, Ma A, Zheng Y, Starczynowski DT. Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs. Nat Immunol. 2020;21:535\u201345. https:\/\/doi.org\/10.1038\/s41590-020-0663-z.","journal-title":"Nat Immunol"},{"key":"1654_CR92","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, Pierre JF, Ernest JD, Galipeau HJ, Thuille N, Bouziat R, Buscarlet M, Ringus DL, Wang Y, Li Y, Dinh V, Kim SM, McDonald BD, Zurenski MA, Musch MW, Furtado GC, Lira SA, Baier G, Chang EB, Eren AM, Weber CR, Busque L, Godley LA, Verd\u00fa EF, Barreiro LB, Jabri B. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature. 2018;557:580\u20134. https:\/\/doi.org\/10.1038\/s41586-018-0125-z.","journal-title":"Nature"},{"key":"1654_CR93","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","volume":"21","author":"CC Coombs","year":"2017","unstructured":"Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, Hyman DM, Solit DB, Robson ME, Baselga J, Arcila ME, Ladanyi M, Tallman MS, Levine RL, Berger MF. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 2017;21:374-382.e374. https:\/\/doi.org\/10.1016\/j.stem.2017.07.010.","journal-title":"Cell Stem Cell"},{"key":"1654_CR94","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick AG, Weinstock JS, Nandakumar SK, Fulco CP, Bao EL, Zekavat SM, Szeto MD, Liao X, Leventhal MJ, Nasser J, Chang K, Laurie C, Burugula BB, Gibson CJ, Lin AE, Taub MA, Aguet F, Ardlie K, Mitchell BD, Barnes KC, Moscati A, Fornage M, Redline S, Psaty BM, Silverman EK, Weiss ST, Palmer ND, Vasan RS, Burchard EG, Kardia SLR, et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020;586:763\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2819-2.","journal-title":"Nature"},{"key":"1654_CR95","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.stem.2021.07.006","volume":"28","author":"J Gopakumar","year":"2021","unstructured":"Gopakumar J, Jaiswal S. Infection makes micro-CHIPs into macro-CHIPs. Cell Stem Cell. 2021;28:1335\u20136. https:\/\/doi.org\/10.1016\/j.stem.2021.07.006.","journal-title":"Cell Stem Cell"},{"key":"1654_CR96","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","volume":"80","author":"CRC Zhang","year":"2019","unstructured":"Zhang CRC, Nix D, Gregory M, Ciorba MA, Ostrander EL, Newberry RD, Spencer DH, Challen GA. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol. 2019;80:36-41.e33. https:\/\/doi.org\/10.1016\/j.exphem.2019.11.008.","journal-title":"Exp Hematol"},{"key":"1654_CR97","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.exphem.2019.12.005","volume":"83","author":"KY King","year":"2020","unstructured":"King KY, Huang Y, Nakada D, Goodell MA. Environmental influences on clonal hematopoiesis. Exp Hematol. 2020;83:66\u201373. https:\/\/doi.org\/10.1016\/j.exphem.2019.12.005.","journal-title":"Exp Hematol"},{"key":"1654_CR98","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/7651_2019_216","volume":"2045","author":"B Snetsinger","year":"2019","unstructured":"Snetsinger B, Ferrone CK, Rauh MJ. Targeted, amplicon-based, next-generation sequencing to detect age-related clonal hematopoiesis. Methods Mol Biol. 2019;2045:167\u201380. https:\/\/doi.org\/10.1007\/7651_2019_216.","journal-title":"Methods Mol Biol"},{"key":"1654_CR99","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/clinchem\/hvaa088","volume":"66","author":"YK Min","year":"2020","unstructured":"Min YK, Lee YK, Nam SH, Kim JK, Park KS, Kim JW. Quantitative and qualitative QC of next-generation sequencing for detecting somatic variants: an example of detecting clonal hematopoiesis of indeterminate potential. Clin Chem. 2020;66:832\u201341. https:\/\/doi.org\/10.1093\/clinchem\/hvaa088.","journal-title":"Clin Chem"},{"key":"1654_CR100","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood.2022015853","volume":"140","author":"EJ Duncavage","year":"2022","unstructured":"Duncavage EJ, Bagg A, Hasserjian RA-O, DiNardo CA-O, Godley LA-O, Iacobucci IA-O, Jaiswal SA-O, Malcovati LA-O, Vannucchi AA-O, Patel KA-O, Arber DA-O, Arcila ME, Bejar RA-O, Berliner N, Borowitz MJ, Branford SA-O, Brown AA-O, Cargo CA, D\u00f6hner HA-O, Falini BA-O, Garcia-Manero G, Haferlach T, Hellstr\u00f6m-Lindberg E, Kim AA-O, Klco JM, Komrokji RA-O, Lee-Cheun Loh M, Loghavi SA-O, Mullighan CA-O, Ogawa SA-O, et al. Genomic profiling for clinical decision making in\u00a0myeloid neoplasms and acute leukemia. Blood. 2022;140:2228\u201347.","journal-title":"Blood"},{"key":"1654_CR101","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41587-021-00900-z","volume":"39","author":"JD Cohen","year":"2021","unstructured":"Cohen JD, Douville C, Dudley JC, Mog BJ, Popoli M, Ptak J, Dobbyn L, Silliman N, Schaefer J, Tie J, Gibbs P, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B. Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands. Nat Biotechnol. 2021;39:1220\u20137. https:\/\/doi.org\/10.1038\/s41587-021-00900-z.","journal-title":"Nat Biotechnol"},{"key":"1654_CR102","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3324\/haematol.2018.215269","volume":"104","author":"AL Young","year":"2019","unstructured":"Young AL, Tong RS, Birmann BM, Druley TE. Clonal hematopoiesis and risk of acute myeloid leukemia. Haematologica. 2019;104:2410\u20137. https:\/\/doi.org\/10.3324\/haematol.2018.215269.","journal-title":"Haematologica"},{"key":"1654_CR103","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41591-018-0081-z","volume":"24","author":"P Desai","year":"2018","unstructured":"Desai P, Mencia-Trinchant N, Savenkov O, Simon MS, Cheang G, Lee S, Samuel M, Ritchie EK, Guzman ML, Ballman KV, Roboz GJ, Hassane DC. Somatic mutations precede acute myeloid leukemia years before diagnosis. Nat Med. 2018;24:1015\u201323. https:\/\/doi.org\/10.1038\/s41591-018-0081-z.","journal-title":"Nat Med"},{"key":"1654_CR104","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson S, Collord G, Ng SWK, Weissbrod O, Mendelson Cohen N, Niemeyer E, Barda N, Zuzarte PC, Heisler L, Sundaravadanam Y, Luben R, Hayat S, Wang TT, Zhao Z, Cirlan I, Pugh TJ, Soave D, Ng K, Latimer C, Hardy C, Raine K, Jones D, Hoult D, Britten A, McPherson JD, Johansson M, Mbabaali F, Eagles J, Miller JK, Pasternack D, et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018;559:400\u20134. https:\/\/doi.org\/10.1038\/s41586-018-0317-6.","journal-title":"Nature"},{"key":"1654_CR105","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","volume":"42","author":"B Assmus","year":"2021","unstructured":"Assmus B, Cremer S, Kirschbaum K, Culmann D, Kiefer K, Dorsheimer L, Rasper T, Abou-El-Ardat K, Herrmann E, Berkowitsch A, Hoffmann J, Seeger F, Mas-Peiro S, Rieger MA, Dimmeler S, Zeiher AM. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. Eur Heart J. 2021;42:257\u201365. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa845.","journal-title":"Eur Heart J"},{"key":"1654_CR106","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11886-022-01724-2","volume":"24","author":"B Haring","year":"2022","unstructured":"Haring B, Wissel S, Manson JE. Somatic mutations and clonal hematopoiesis as drivers of age-related cardiovascular risk. Curr Cardiol Rep. 2022;24:1049\u201358. https:\/\/doi.org\/10.1007\/s11886-022-01724-2.","journal-title":"Curr Cardiol Rep"},{"key":"1654_CR107","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/life12081135","volume":"12","author":"C Gaulin","year":"2022","unstructured":"Gaulin C, Kelemen K, Arana Yi C. Molecular pathways in clonal hematopoiesis: from the acquisition of somatic mutations to transformation into hematologic neoplasm. Life (Basel). 2022;12:1135. https:\/\/doi.org\/10.3390\/life12081135.","journal-title":"Life (Basel)"},{"key":"1654_CR108","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/blood.2021014235","volume":"139","author":"DWL Chin","year":"2022","unstructured":"Chin DWL, Yoshizato T, Virding Culleton S, Grasso F, Barbachowska M, Ogawa S, Jacobsen SEW, Woll PS. Aged healthy mice acquire clonal hematopoiesis mutations. Blood. 2022;139:629\u201334. https:\/\/doi.org\/10.1182\/blood.2021014235.","journal-title":"Blood"},{"key":"1654_CR109","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1182\/blood.2021014875","volume":"140","author":"TH Shin","year":"2022","unstructured":"Shin TH, Zhou Y, Chen S, Cordes S, Grice MZ, Fan X, Lee BC, Aljanahi AA, Hong SG, Vaughan KL, Mattison JA, Kohama SG, Fabre MA, Uchida N, Demirci S, Corat MAF, Metais JY, Calvo KR, Buscarlet M, Natanson H, McGraw KL, List AF, Busque L, Tisdale JF, Vassiliou GS, Yu KR, Dunbar CE. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions. Blood. 2022;140:1774\u201389. https:\/\/doi.org\/10.1182\/blood.2021014875.","journal-title":"Blood"},{"key":"1654_CR110","doi-asserted-by":"publisher","unstructured":"Jeong M, Park HJ, Celik H, Ostrander EL, Reyes JM, Guzman A, Rodriguez B, Lei Y, Lee Y, Ding L, Guryanova OA, Li W, Goodell MA, Challen GA. Loss of DNMT3A immortalizes hematopoietic stem cells in vivo. 2018. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.025","DOI":"10.1016\/j.celrep.2018.03.025"},{"key":"1654_CR111","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2011","unstructured":"Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, Bock C, Vasanthakumar A, Gu H, Xi Y, Liang S, Lu Y, Darlington GJ, Meissner A, Issa JP, Godley LA, Li W, Goodell MA. DNMT3A is essential for hematopoietic stem cell differentiation. Nat Genet. 2011;44:23\u201331. https:\/\/doi.org\/10.1038\/ng.1009.","journal-title":"Nat Genet"},{"key":"1654_CR112","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, Katanasaka Y, Sano M, Walsh K. CRISPR-mediated gene editing to assess the roles of Tet2 and DNMT3A in clonal hematopoiesis and cardiovascular disease. Circ Res. 2018;123:335\u201341. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313225.","journal-title":"Circ Res"},{"key":"1654_CR113","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1161\/CIRCRESAHA.120.317104","volume":"128","author":"WT Abplanalp","year":"2021","unstructured":"Abplanalp WT, Cremer S, John D, Hoffmann J, Schuhmacher B, Merten M, Rieger MA, Vasa-Nicotera M, Zeiher AM, Dimmeler S. Clonal hematopoiesis-driver DNMT3A mutations alter immune cells in heart failure. Circ Res. 2021;128:216\u201328. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317104.","journal-title":"Circ Res"},{"key":"1654_CR114","doi-asserted-by":"publisher","unstructured":"Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, Zuriaga MA, Yoshiyama M, Goukassian D, Cooper MA, Fuster JJ, Walsh K. Tet2-mediated clonal hematopoiesis accelerates heart failure through a\u00a0mechanism involving the IL-1\u03b2\/NLRP3\u00a0inflammasome. 2018. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.037","DOI":"10.1016\/j.jacc.2017.12.037"},{"key":"1654_CR115","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrm3589","volume":"14","author":"WA Pastor","year":"2013","unstructured":"Pastor WA, Aravind L, Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol. 2013;14:341\u201356. https:\/\/doi.org\/10.1038\/nrm3589.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1654_CR116","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1016\/j.celrep.2019.07.094","volume":"28","author":"K Ito","year":"2019","unstructured":"Ito K, Lee J, Chrysanthou S, Zhao Y, Josephs K, Sato H, Teruya-Feldstein J, Zheng D, Dawlaty MM, Ito K. Non-catalytic roles of Tet2 are essential to regulate hematopoietic stem and progenitor cell homeostasis. Cell Rep. 2019;28:2480-2490.e2484. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.094.","journal-title":"Cell Rep"},{"key":"1654_CR117","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, Wu CL, Sano S, Muralidharan S, Rius C, Vuong J, Jacob S, Muralidhar V, Robertson AA, Cooper MA, Andres V, Hirschi KK, Martin KA, Walsh K. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355:842\u20137. https:\/\/doi.org\/10.1126\/science.aag1381.","journal-title":"Science"},{"key":"1654_CR118","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X, Su X, Liu J, Ge W, Levine RL, Li N, Cao X. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015;525:389\u201393. https:\/\/doi.org\/10.1038\/nature15252.","journal-title":"Nature"},{"key":"1654_CR119","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/circulationaha.119.044362","volume":"141","author":"AG Bick","year":"2020","unstructured":"Bick AG, Pirruccello JP, Griffin GK, Gupta N, Gabriel S, Saleheen D, Libby P, Kathiresan S, Natarajan P. Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation. 2020;141:124\u201331. https:\/\/doi.org\/10.1161\/circulationaha.119.044362.","journal-title":"Circulation"},{"key":"1654_CR120","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41586-018-0350-5","volume":"559","author":"D Wu","year":"2018","unstructured":"Wu D, Hu D, Chen H, Shi G, Fetahu IS, Wu F, Rabidou K, Fang R, Tan L, Xu S, Liu H, Argueta C, Zhang L, Mao F, Yan G, Chen J, Dong Z, Lv R, Xu Y, Wang M, Ye Y, Zhang S, Duquette D, Geng S, Yin C, Lian CG, Murphy GF, Adler GK, Garg R, Lynch L, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018;559:637\u201341. https:\/\/doi.org\/10.1038\/s41586-018-0350-5.","journal-title":"Nature"},{"key":"1654_CR121","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11745-014-3977-5","volume":"50","author":"G Li","year":"2015","unstructured":"Li G, Peng J, Liu Y, Li X, Yang Q, Li Y, Tang Z, Wang Z, Jiang Z, Wei D. Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation. Lipids. 2015;50:177\u201383. https:\/\/doi.org\/10.1007\/s11745-014-3977-5.","journal-title":"Lipids"},{"key":"1654_CR122","doi-asserted-by":"publisher","first-page":"108326","DOI":"10.1016\/j.celrep.2020.108326","volume":"33","author":"JJ Fuster","year":"2020","unstructured":"Fuster JJ, Zuriaga MA, Zorita V, MacLauchlan S, Polackal MN, Viana-Huete V, Ferrer-Perez A, Matesanz N, Herrero-Cervera A, Sano S, Cooper MA, Gonzalez-Navarro H, Walsh K. TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity. Cell Rep. 2020;33:108326. https:\/\/doi.org\/10.1016\/j.celrep.2020.108326.","journal-title":"Cell Rep"},{"key":"1654_CR123","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.2337\/dc23-0805","volume":"46","author":"DK Tobias","year":"2023","unstructured":"Tobias DK, Manning AK, Wessel J, Raghavan S, Westerman KE, Bick AG, Dicorpo D, Whitsel EA, Collins J, Correa A, Cupples LA, Dupuis J, Goodarzi MO, Guo X, Howard B, Lange LA, Liu S, Raffield LM, Reiner AP, Rich SS, Taylor KD, Tinker L, Wilson JG, Wu P, Carson AP, Vasan RS, Fornage M, Psaty BM, Kooperberg C, Rotter JI, et al. Clonal hematopoiesis of indeterminate potential (CHIP) and incident type 2 diabetes risk. Diabetes Care. 2023;46:1978\u201385. https:\/\/doi.org\/10.2337\/dc23-0805.","journal-title":"Diabetes Care"},{"key":"1654_CR124","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","volume":"23","author":"Z Cai","year":"2018","unstructured":"Cai Z, Kotzin JJ, Ramdas B, Chen S, Nelanuthala S, Palam LR, Pandey R, Mali RS, Liu Y, Kelley MR, Sandusky G, Mohseni M, Williams A, Henao-Mejia J, Kapur R. Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis. Cell Stem Cell. 2018;23:833-849.e835. https:\/\/doi.org\/10.1016\/j.stem.2018.10.013.","journal-title":"Cell Stem Cell"},{"key":"1654_CR125","doi-asserted-by":"publisher","first-page":"e20201541","DOI":"10.1084\/jem.20201541","volume":"218","author":"F Caiado","year":"2021","unstructured":"Caiado F, Pietras EM, Manz MG. Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med. 2021;218:e20201541. https:\/\/doi.org\/10.1084\/jem.20201541.","journal-title":"J Exp Med"},{"key":"1654_CR126","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fonc.2016.00151","volume":"6","author":"DA Sallman","year":"2016","unstructured":"Sallman DA, Cluzeau T, Basiorka AA, List A. Unraveling the pathogenesis of MDS: the NLRP3 inflammasome and pyroptosis drive the MDS phenotype. Front Oncol. 2016;6:151. https:\/\/doi.org\/10.3389\/fonc.2016.00151.","journal-title":"Front Oncol"},{"key":"1654_CR127","doi-asserted-by":"publisher","first-page":"106457","DOI":"10.1016\/j.leukres.2020.106457","volume":"98","author":"H Kunimoto","year":"2020","unstructured":"Kunimoto H, Nakajima H. Clonal hematopoiesis: molecular basis and clinical relevance. Leuk Res. 2020;98:106457. https:\/\/doi.org\/10.1016\/j.leukres.2020.106457.","journal-title":"Leuk Res"},{"key":"1654_CR128","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-021-22053-y","volume":"12","author":"T Fujino","year":"2021","unstructured":"Fujino T, Goyama S, Sugiura Y, Inoue D, Asada S, Yamasaki S, Matsumoto A, Yamaguchi K, Isobe Y, Tsuchiya A, Shikata S, Sato N, Morinaga H, Fukuyama T, Tanaka Y, Fukushima T, Takeda R, Yamamoto K, Honda H, Nishimura EK, Furukawa Y, Shibata T, Abdel-Wahab O, Suematsu M, Kitamura T. Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt\/mTOR pathway. Nat Commun. 2021;12:1826. https:\/\/doi.org\/10.1038\/s41467-021-22053-y.","journal-title":"Nat Commun"},{"key":"1654_CR129","doi-asserted-by":"publisher","first-page":"e026154","DOI":"10.1161\/jaha.122.026154","volume":"11","author":"KD Min","year":"2022","unstructured":"Min KD, Polizio AH, Kour A, Thel MC, Walsh K. Experimental ASXL1-mediated clonal hematopoiesis promotes inflammation and accelerates heart failure. J Am Heart Assoc. 2022;11:e026154. https:\/\/doi.org\/10.1161\/jaha.122.026154.","journal-title":"J Am Heart Assoc"},{"key":"1654_CR130","doi-asserted-by":"publisher","first-page":"e168597","DOI":"10.1172\/jci168597","volume":"133","author":"Z Yu","year":"2023","unstructured":"Yu Z, Fidler TP, Ruan Y, Vlasschaert C, Nakao T, Uddin MM, Mack T, Niroula A, Heimlich JB, Zekavat SM, Gibson CJ, Griffin GK, Wang Y, Peloso GM, Heard-Costa N, Levy D, Vasan RS, Aguet F, Ardlie KG, Taylor KD, Rich SS, Rotter JI, Libby P, Jaiswal S, Ebert BL, Bick AG, Tall AR, Natarajan P. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk. J Clin Invest. 2023;133:e168597. https:\/\/doi.org\/10.1172\/jci168597.","journal-title":"J Clin Invest"},{"key":"1654_CR131","doi-asserted-by":"publisher","first-page":"e187529","DOI":"10.1172\/JCI187529","volume":"135","author":"K Campbell","year":"2025","unstructured":"Campbell K, Li Q. Clonal hematopoiesis JAKs up plaque formation. J Clin Invest. 2025;135:e187529. https:\/\/doi.org\/10.1172\/JCI187529.","journal-title":"J Clin Invest"},{"key":"1654_CR132","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1071545","volume":"296","author":"DS Aaronson","year":"2002","unstructured":"Aaronson DS, Horvath CM. A road map for those who don\u2019t know JAK-STAT. Science. 2002;296:1653\u20135. https:\/\/doi.org\/10.1126\/science.1071545.","journal-title":"Science"},{"key":"1654_CR133","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.Cd-18-1138","volume":"9","author":"JJ Jeong","year":"2019","unstructured":"Jeong JJ, Gu X, Nie J, Sundaravel S, Liu H, Kuo WL, Bhagat TD, Pradhan K, Cao J, Nischal S, McGraw KL, Bhattacharyya S, Bishop MR, Artz A, Thirman MJ, Moliterno A, Ji P, Levine RL, Godley LA, Steidl U, Bieker JJ, List AF, Saunthararajah Y, He C, Verma A, Wickrema A. Cytokine-regulated phosphorylation and activation of TET2 by JAK2 in hematopoiesis. Cancer Discov. 2019;9:778\u201395. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-1138.","journal-title":"Cancer Discov"},{"key":"1654_CR134","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP, Staerk J, Delhommeau F, Lacout C, Gar\u00e7on L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144\u20138. https:\/\/doi.org\/10.1038\/nature03546.","journal-title":"Nature"},{"key":"1654_CR135","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1182\/blood.v98.7.2101","volume":"98","author":"T Ogura","year":"2001","unstructured":"Ogura T, Ueda H, Hosohara K, Tsuji R, Nagata Y, Kashiwamura S, Okamura H. Interleukin-18 stimulates hematopoietic cytokine and growth factor formation and augments circulating granulocytes in mice. Blood. 2001;98:2101\u20137. https:\/\/doi.org\/10.1182\/blood.v98.7.2101.","journal-title":"Blood"},{"key":"1654_CR136","doi-asserted-by":"publisher","first-page":"e182939","DOI":"10.1172\/JCI182939","volume":"135","author":"W Liu","year":"2024","unstructured":"Liu W, Hardaway BD, Kim E, Pauli J, Wettich JL, Yalcinkaya M, Hsu CC, Xiao T, Reilly MP, Tabas I, Maegdefessel L, Schlepckow K, Haass C, Wang N, Tall AR. Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice. J Clin Invest. 2024;135:e182939. https:\/\/doi.org\/10.1172\/JCI182939.","journal-title":"J Clin Invest"},{"key":"1654_CR137","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/circresaha.118.313283","volume":"123","author":"W Wang","year":"2018","unstructured":"Wang W, Liu W, Fidler T, Wang Y, Tang Y, Woods B, Welch C, Cai B, Silvestre-Roig C, Ai D, Yang YG, Hidalgo A, Soehnlein O, Tabas I, Levine RL, Tall AR, Wang N. Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) mice. Circ Res. 2018;123:e35\u201347. https:\/\/doi.org\/10.1161\/circresaha.118.313283.","journal-title":"Circ Res"},{"key":"1654_CR138","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacbts.2019.05.013","volume":"4","author":"S Sano","year":"2019","unstructured":"Sano S, Wang Y, Yura Y, Sano M, Oshima K, Yang Y, Katanasaka Y, Min KD, Matsuura S, Ravid K, Mohi G, Walsh K. JAK2 (V617F)-mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure. JACC Basic Transl Sci. 2019;4:684\u201397. https:\/\/doi.org\/10.1016\/j.jacbts.2019.05.013.","journal-title":"JACC Basic Transl Sci"},{"key":"1654_CR139","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","volume":"592","author":"TP Fidler","year":"2021","unstructured":"Fidler TP, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, Liu W, Thomas DG, Hajebrahimi MA, Pircher J, Silvestre-Roig C, Kotini AG, Luchsinger LL, Wei Y, Westerterp M, Snoeck HW, Papapetrou EP, Schulz C, Massberg S, Soehnlein O, Ebert B, Levine RL, Reilly MP, Libby P, Wang N, Tall AR. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature. 2021;592:296\u2013301. https:\/\/doi.org\/10.1038\/s41586-021-03341-5.","journal-title":"Nature"},{"key":"1654_CR140","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1172\/jci90312","volume":"128","author":"B Edelmann","year":"2018","unstructured":"Edelmann B, Gupta N, Schnoeder TM, Oelschlegel AM, Shahzad K, Goldschmidt J, Philipsen L, Weinert S, Ghosh A, Saalfeld FC, Nimmagadda SC, M\u00fcller P, Braun-Dullaeus R, Mohr J, Wolleschak D, Kliche S, Amthauer H, Heidel FH, Schraven B, Isermann B, M\u00fcller AJ, Fischer T. JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation. J Clin Invest. 2018;128:4359\u201371. https:\/\/doi.org\/10.1172\/jci90312.","journal-title":"J Clin Invest"},{"key":"1654_CR141","doi-asserted-by":"publisher","first-page":"eaan8292","DOI":"10.1126\/scitranslmed.aan8292","volume":"10","author":"O Wolach","year":"2018","unstructured":"Wolach O, Sellar RS, Martinod K, Cherpokova D, McConkey M, Chappell RJ, Silver AJ, Adams D, Castellano CA, Schneider RK, Padera RF, DeAngelo DJ, Wadleigh M, Steensma DP, Galinsky I, Stone RM, Genovese G, McCarroll SA, Iliadou B, Hultman C, Neuberg D, Mullally A, Wagner DD, Ebert BL. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. 2018;10:eaan8292. https:\/\/doi.org\/10.1126\/scitranslmed.aan8292.","journal-title":"Sci Transl Med"},{"key":"1654_CR142","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007;28:622\u20139. https:\/\/doi.org\/10.1002\/humu.20495.","journal-title":"Hum Mutat"},{"key":"1654_CR143","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrm2395","volume":"9","author":"T Riley","year":"2008","unstructured":"Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008;9:402\u201312. https:\/\/doi.org\/10.1038\/nrm2395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1654_CR144","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton KL, Ptashkin RN, Gao T, Braunstein L, Devlin SM, Kelly D, Patel M, Berthon A, Syed A, Yabe M, Coombs CC, Caltabellotta NM, Walsh M, Offit K, Stadler Z, Mandelker D, Schulman J, Patel A, Philip J, Bernard E, Gundem G, Ossa JEA, Levine M, Martinez JSM, Farnoud N, Glodzik D, Li S, Robson ME, Lee C, Pharoah PDP, et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020;52:1219\u201326. https:\/\/doi.org\/10.1038\/s41588-020-00710-0.","journal-title":"Nat Genet"},{"key":"1654_CR145","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1182\/blood.2020006158","volume":"136","author":"DA Sallman","year":"2020","unstructured":"Sallman DA, McLemore AF, Aldrich AL, Komrokji RS, McGraw KL, Dhawan A, Geyer S, Hou HA, Eksioglu EA, Sullivan A, Warren S, MacBeth KJ, Meggendorfer M, Haferlach T, Boettcher S, Ebert BL, Al Ali NH, Lancet JE, Cleveland JL, Padron E, List AF. TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype. Blood. 2020;136:2812\u201323. https:\/\/doi.org\/10.1182\/blood.2020006158.","journal-title":"Blood"},{"key":"1654_CR146","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1002\/ijc.33481","volume":"148","author":"R Okamura","year":"2021","unstructured":"Okamura R, Piccioni DE, Boichard A, Lee S, Jimenez RE, Sicklick JK, Kato S, Kurzrock R. High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment. Int J Cancer. 2021;148:2839\u201347. https:\/\/doi.org\/10.1002\/ijc.33481.","journal-title":"Int J Cancer"},{"key":"1654_CR147","doi-asserted-by":"publisher","first-page":"e146076","DOI":"10.1172\/jci.insight.146076","volume":"6","author":"S Sano","year":"2021","unstructured":"Sano S, Wang Y, Ogawa H, Horitani K, Sano M, Polizio AH, Kour A, Yura Y, Doviak H, Walsh K. TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response. JCI Insight. 2021;6:e146076. https:\/\/doi.org\/10.1172\/jci.insight.146076.","journal-title":"JCI Insight"},{"key":"1654_CR148","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.4161\/cc.25694","volume":"12","author":"C Dudgeon","year":"2013","unstructured":"Dudgeon C, Shreeram S, Tanoue K, Mazur SJ, Sayadi A, Robinson RC, Appella E, Bulavin DV. Genetic variants and mutations of PPM1D control the response to DNA damage. Cell Cycle. 2013;12:2656\u201364. https:\/\/doi.org\/10.4161\/cc.25694.","journal-title":"Cell Cycle"},{"key":"1654_CR149","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1083\/jcb.201210031","volume":"201","author":"P Kleiblova","year":"2013","unstructured":"Kleiblova P, Shaltiel IA, Benada J, \u0160ev\u010d\u00edk J, Pech\u00e1\u010dkov\u00e1 S, Pohlreich P, Voest EE, Dundr P, Bartek J, Kleibl Z, Medema RH, Macurek L. Gain-of-function mutations of PPM1D\/Wip1 impair the p53-dependent G1 checkpoint. J Cell Biol. 2013;201:511\u201321. https:\/\/doi.org\/10.1083\/jcb.201210031.","journal-title":"J Cell Biol"},{"key":"1654_CR150","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2018-05-850339","volume":"132","author":"JD Kahn","year":"2018","unstructured":"Kahn JD, Miller PG, Silver AJ, Sellar RS, Bhatt S, Gibson C, McConkey M, Adams D, Mar B, Mertins P, Fereshetian S, Krug K, Zhu H, Letai A, Carr SA, Doench J, Jaiswal S, Ebert BL. PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. 2018;132:1095\u2013105. https:\/\/doi.org\/10.1182\/blood-2018-05-850339.","journal-title":"Blood"},{"key":"1654_CR151","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/jpm10030094","volume":"10","author":"G Hoermann","year":"2020","unstructured":"Hoermann G, Greiner G, Griesmacher A, Valent P. Clonal hematopoiesis of indeterminate potential: a multidisciplinary challenge in personalized hematology. J Pers Med. 2020;10:94. https:\/\/doi.org\/10.3390\/jpm10030094.","journal-title":"J Pers Med"},{"key":"1654_CR152","doi-asserted-by":"publisher","first-page":"E392","DOI":"10.1002\/ajh.26297","volume":"96","author":"Y Kusne","year":"2021","unstructured":"Kusne Y, Lasho T, Mangaonkar A, Tefferi A, Gangat N, Finke C, Binder M, Chia N, Patnaik MM. Remarkable stability in clonal hematopoiesis involving leukemia-driver genes in patients without underlying myeloid neoplasms. Am J Hematol. 2021;96:E392-e396. https:\/\/doi.org\/10.1002\/ajh.26297.","journal-title":"Am J Hematol"},{"key":"1654_CR153","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/s41375-020-0869-y","volume":"34","author":"D Midic","year":"2020","unstructured":"Midic D, Rinke J, Perner F, M\u00fcller V, Hinze A, Pester F, Landschulze J, Ernst J, Gruhn B, Matziolis G, Heidel FH, Hochhaus A, Ernst T. Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders. Leukemia. 2020;34:2198\u2013205. https:\/\/doi.org\/10.1038\/s41375-020-0869-y.","journal-title":"Leukemia"},{"key":"1654_CR154","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.ebiom.2023.104621","volume":"92","author":"JC Andersson-Assarsson","year":"2023","unstructured":"Andersson-Assarsson JC, van Deuren RC, Kristensson FM, Steehouwer M, Sj\u00f6holm K, Svensson PA, Pieterse M, Gilissen C, Taube M, Jacobson P, Perkins R, Brunner HG, Netea MG, Peltonen M, Carlsson B, Hoischen A, Carlsson LMS. Evolution of age-related mutation-driven clonal haematopoiesis over 20 years is associated with metabolic dysfunction in obesity. EBioMedicine. 2023;92:104621. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104621.","journal-title":"EBioMedicine"},{"key":"1654_CR155","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12979-022-00278-9","volume":"19","author":"MM Uddin","year":"2022","unstructured":"Uddin MM, Zhou Y, Bick AG, Burugula BB, Jaiswal S, Desai P, Honigberg MC, Love SA, Barac A, Hayden KM, Manson JE, Whitsel EA, Kooperberg C, Natarajan P, Reiner AP, Kitzman JO. Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics. Immun Ageing. 2022;19:23. https:\/\/doi.org\/10.1186\/s12979-022-00278-9.","journal-title":"Immun Ageing"},{"key":"1654_CR156","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","volume":"2","author":"DP Steensma","year":"2018","unstructured":"Steensma DP. Clinical consequences of clonal hematopoiesis of indeterminate potential. Blood Adv. 2018;2:3404\u201310. https:\/\/doi.org\/10.1182\/bloodadvances.2018020222.","journal-title":"Blood Adv"},{"key":"1654_CR157","doi-asserted-by":"publisher","first-page":"e180069","DOI":"10.1172\/JCI180069","volume":"134","author":"K Takahashi","year":"2024","unstructured":"Takahashi K, Nakada D, Goodell M. Distinct landscape and clinical implications of therapy-related clonal hematopoiesis. J Clin Invest. 2024;134:e180069. https:\/\/doi.org\/10.1172\/JCI180069.","journal-title":"J Clin Invest"},{"key":"1654_CR158","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jnci\/djad065","volume":"115","author":"C Mayerhofer","year":"2023","unstructured":"Mayerhofer C, Sedrak MS, Hopkins JO, Li T, Tayob N, Faggen MG, Sinclair NF, Chen WY, Parsons HA, Mayer EL, Lange PB, Basta AS, Perilla-Glen A, Lederman RI, Wong AR, Tiwari A, McAllister SS, Mittendorf EA, Gibson CJ, Burstein HJ, Kim AS, Freedman RA, Miller PG. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy. J Natl Cancer Inst. 2023;115:981\u20138. https:\/\/doi.org\/10.1093\/jnci\/djad065.","journal-title":"J Natl Cancer Inst"},{"key":"1654_CR159","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41375-024-02253-3","volume":"38","author":"CM Arends","year":"2024","unstructured":"Arends CM, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll UM, Zeillinger R, Schmitt WD, Sehouli J, Kulbe H, Fleischmann M, Ray-Coquard I, Zeimet A, Raspagliesi F, Zamagni C, Vergote I, Lorusso D, Concin N, Bullinger L, Braicu EI, Damm F. Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer. Leukemia. 2024;38:1378\u201389. https:\/\/doi.org\/10.1038\/s41375-024-02253-3.","journal-title":"Leukemia"},{"key":"1654_CR160","doi-asserted-by":"publisher","first-page":"101269","DOI":"10.1016\/j.blre.2025.101269","volume":"70","author":"CH Marshall","year":"2025","unstructured":"Marshall CH, Antonarakis ES, Patnaik MM. Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: the good, the bad, the ugly. Blood Rev. 2025;70:101269. https:\/\/doi.org\/10.1016\/j.blre.2025.101269.","journal-title":"Blood Rev"},{"key":"1654_CR161","doi-asserted-by":"publisher","first-page":"e2351927","DOI":"10.1001\/jamanetworkopen.2023.51927","volume":"7","author":"S Saadatagah","year":"2024","unstructured":"Saadatagah S, Uddin MM, Weeks LD, Niroula A, Ru M, Takahashi K, Gondek L, Yu B, Bick AG, Ebert BL, Platz EA, Natarajan P, Ballantyne CM. Clonal hematopoiesis risk score and all-cause and cardiovascular mortality in older adults. JAMA Netw Open. 2024;7:e2351927. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.51927.","journal-title":"JAMA Netw Open"},{"key":"1654_CR162","doi-asserted-by":"publisher","first-page":"EVIDe2300053","DOI":"10.1056\/EVIDe2300053","volume":"2","author":"Z Xie","year":"2023","unstructured":"Xie Z, DeZern AE. How great is the threat of clonal hematopoiesis? Let this new risk score be your guide. NEJM Evid. 2023;2:EVIDe2300053. https:\/\/doi.org\/10.1056\/EVIDe2300053.","journal-title":"NEJM Evid."},{"key":"1654_CR163","doi-asserted-by":"publisher","unstructured":"Weeks LD, Niroula A, Neuberg D, Wong W, Lindsley RC, Luskin M, Berliner N, Stone RM, DeAngelo DJ, Soiffer R, Uddin MM, Griffin G, Vlasschaert C, Gibson CJ, Jaiswal S, Bick AG, Malcovati L, Natarajan P, Ebert BL. Prediction of risk for myeloid malignancy in clonal hematopoiesis. NEJM Evid. 2023;2. https:\/\/doi.org\/10.1056\/evidoa2200310","DOI":"10.1056\/evidoa2200310"},{"key":"1654_CR164","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41588-023-01472-1","volume":"55","author":"M Gu","year":"2023","unstructured":"Gu M, Kovilakam SC, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, Cargo CA, Malcovati L, Quiros PM, Vassiliou GS. Multiparameter prediction of myeloid neoplasia risk. Nat Genet. 2023;55:1523\u201330. https:\/\/doi.org\/10.1038\/s41588-023-01472-1.","journal-title":"Nat Genet"},{"key":"1654_CR165","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1182\/blood.2019000991","volume":"136","author":"JT Warren","year":"2020","unstructured":"Warren JT, Link DC. Clonal hematopoiesis and risk for hematologic malignancy. Blood. 2020;136:1599\u2013605. https:\/\/doi.org\/10.1182\/blood.2019000991.","journal-title":"Blood"},{"key":"1654_CR166","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/j.seminhematol.2024.01.004","volume":"61","author":"C Bravo-Perez","year":"2024","unstructured":"Bravo-Perez C, Gurnari C. A tower of babel of acronyms? The shadowlands of MGUS\/MBL\/CHIP\/TCUS. Semin Hematol. 2024;61:43\u201350. https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.004.","journal-title":"Semin Hematol"},{"key":"1654_CR167","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.trsl.2022.11.009","volume":"255","author":"YA Jakubek","year":"2023","unstructured":"Jakubek YA, Reiner AP, Honigberg MC. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations. Transl Res. 2023;255:171\u201380. https:\/\/doi.org\/10.1016\/j.trsl.2022.11.009.","journal-title":"Transl Res"},{"key":"1654_CR168","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick AG, Weinstock JS, Nandakumar SK, Fulco CP, Bao EL, Zekavat SM, Szeto MD, Liao X, Leventhal MJ, Nasser J, Chang K, Laurie C, Burugula BB, Gibson CJ, Lin AE, Taub MA, Aguet F, Ardlie K, Mitchell BD, Barnes KC, Moscati A, Fornage M, Redline S, Psaty BM, Silverman EK, Weiss ST, Palmer ND, Vasan RS, Burchard EG, Kardia SLR, et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020;586:763\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2819-2.","journal-title":"Nature"},{"key":"1654_CR169","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar SP, Quiros PM, Gu M, Jiang T, Mitchell J, Langdon R, Iyer V, Barcena C, Vijayabaskar MS, Fabre MA, Carter P, Petrovski S, Burgess S, Vassiliou GS. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat Genet. 2022;54:1155\u201366. https:\/\/doi.org\/10.1038\/s41588-022-01121-z.","journal-title":"Nat Genet"},{"key":"1654_CR170","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","volume":"34","author":"AAZ Dawoud","year":"2020","unstructured":"Dawoud AAZ, Tapper WJ, Cross NCP. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking. Leukemia. 2020;34:2660\u201372. https:\/\/doi.org\/10.1038\/s41375-020-0896-8.","journal-title":"Leukemia"},{"key":"1654_CR171","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamacardio.2021.1678","volume":"6","author":"R Bhattacharya","year":"2021","unstructured":"Bhattacharya R, Zekavat SM, Uddin MM, Pirruccello J, Niroula A, Gibson C, Griffin GK, Libby P, Ebert BL, Bick A, Natarajan P. Association of diet quality with prevalence of clonal hematopoiesis and adverse cardiovascular events. JAMA Cardiol. 2021;6:1069\u201377. https:\/\/doi.org\/10.1001\/jamacardio.2021.1678.","journal-title":"JAMA Cardiol"},{"key":"1654_CR172","doi-asserted-by":"publisher","first-page":"e163968","DOI":"10.1172\/jci163968","volume":"133","author":"SK Pasupuleti","year":"2023","unstructured":"Pasupuleti SK, Ramdas B, Burns SS, Palam LR, Kanumuri R, Kumar R, Pandhiri TR, Dave UP, Yellapu NK, Zhou X, Zhang C, Sandusky GE, Yu Z, Honigberg MC, Bick AG, Griffin GK, Niroula A, Ebert BL, Paczesny S, Natarajan P, Kapur R. Obesity-induced inflammation exacerbates clonal hematopoiesis. J Clin Invest. 2023;133:e163968. https:\/\/doi.org\/10.1172\/jci163968.","journal-title":"J Clin Invest"},{"key":"1654_CR173","doi-asserted-by":"publisher","first-page":"e018789","DOI":"10.1161\/jaha.120.018789","volume":"10","author":"B Haring","year":"2021","unstructured":"Haring B, Reiner AP, Liu J, Tobias DK, Whitsel E, Berger JS, Desai P, Wassertheil-Smoller S, LaMonte MJ, Hayden KM, Bick AG, Natarajan P, Weinstock JS, Nguyen PK, Stefanick M, Simon MS, Eaton CB, Kooperberg C, Manson JE. Healthy lifestyle and clonal hematopoiesis of indeterminate potential: results from the women\u2019s health initiative. J Am Heart Assoc. 2021;10:e018789. https:\/\/doi.org\/10.1161\/jaha.120.018789.","journal-title":"J Am Heart Assoc"},{"key":"1654_CR174","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","volume":"105","author":"CM Arends","year":"2020","unstructured":"Arends CM, Weiss M, Christen F, Eulenberg-Gustavus C, Rousselle A, Kettritz R, Eckardt KU, Chan W, Hoyer K, Frick M, Bullinger L, Bieringer M, Schreiber A, Damm F. Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Haematologica. 2020;105:e264\u20137. https:\/\/doi.org\/10.3324\/haematol.2019.223305.","journal-title":"Haematologica"},{"key":"1654_CR175","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard-2023-224933","volume":"83","author":"F Gutierrez-Rodrigues","year":"2024","unstructured":"Gutierrez-Rodrigues F, Wells KV, Jones AI, Hironaka D, Rankin C, Gadina M, Sikora KA, Alemu L, Calado RT, Quinn KA, Patel B, Young NS, Grayson PC. Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu\u2019s arteritis, ANCA-associated vasculitis and giant cell arteritis. Ann Rheum Dis. 2024;83:508\u201317. https:\/\/doi.org\/10.1136\/ard-2023-224933.","journal-title":"Ann Rheum Dis"},{"key":"1654_CR176","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","volume":"612","author":"MD Kessler","year":"2022","unstructured":"Kessler MD, Damask A, O\u2019Keeffe S, Banerjee N, Li D, Watanabe K, Marketta A, Van Meter M, Semrau S, Horowitz J, Tang J, Kosmicki JA, Rajagopal VM, Zou Y, Houvras Y, Ghosh A, Gillies C, Mbatchou J, White RR, Verweij N, Bovijn J, Parikshak NN, LeBlanc MG, Jones M, Glass DJ, Lotta LA, Cantor MN, Atwal GS, Locke AE, Ferreira MAR, et al. Common and rare variant associations with clonal haematopoiesis phenotypes. Nature. 2022;612:301\u20139. https:\/\/doi.org\/10.1038\/s41586-022-05448-9.","journal-title":"Nature"},{"key":"1654_CR177","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1038\/s41467-021-26138-6","volume":"12","author":"KL Bolton","year":"2021","unstructured":"Bolton KL, Koh Y, Foote MB, Im H, Jee J, Sun CH, Safonov A, Ptashkin R, Moon JH, Lee JY, Jung J, Kang CK, Song KH, Choe PG, Park WB, Kim HB, Oh MD, Song H, Kim S, Patel M, Derkach A, Gedvilaite E, Tkachuk KA, Wiley BJ, Chan IC, Braunstein LZ, Gao T, Papaemmanuil E, Esther Babady N, Pessin MS, et al. Clonal hematopoiesis is associated with risk of severe COVID-19. Nat Commun. 2021;12:5975. https:\/\/doi.org\/10.1038\/s41467-021-26138-6.","journal-title":"Nat Commun"},{"key":"1654_CR178","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/cen.14925","volume":"99","author":"L Boucai","year":"2023","unstructured":"Boucai L, Ptashkin RN, Levine RL, Fagin JA. Effects of radioactive iodine on clonal hematopoiesis in patients with thyroid cancer: a prospective study. Clin Endocrinol (Oxf). 2023;99:122\u20139. https:\/\/doi.org\/10.1111\/cen.14925.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1654_CR179","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3324\/haematol.2023.283727","volume":"109","author":"Z Xie","year":"2024","unstructured":"Xie Z, Lasho T, Khurana A, Ferrer A, Finke C, Mangaonkar AA, Ansell S, Fernandez J, Shah MV, Al-Kali A, Gangat N, Abeykoon J, Witzig TE, Patnaik MM. Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy. Haematologica. 2024;109:509\u201320. https:\/\/doi.org\/10.3324\/haematol.2023.283727.","journal-title":"Haematologica"},{"key":"1654_CR180","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","volume":"23","author":"JI Hsu","year":"2018","unstructured":"Hsu JI, Dayaram T, Tovy A, De Braekeleer E, Jeong M, Wang F, Zhang J, Heffernan TP, Gera S, Kovacs JJ, Marszalek JR, Bristow C, Yan Y, Garcia-Manero G, Kantarjian H, Vassiliou G, Futreal PA, Donehower LA, Takahashi K, Goodell MA. PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell. 2018;23:700-713 e706. https:\/\/doi.org\/10.1016\/j.stem.2018.10.004.","journal-title":"Cell Stem Cell"},{"key":"1654_CR181","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s44161-024-00579-w","volume":"3","author":"N Sato","year":"2024","unstructured":"Sato N, Goyama S, Chang YH, Miyawaki M, Fujino T, Koide S, Denda T, Liu X, Ueda K, Yamamoto K, Asada S, Takeda R, Yonezawa T, Tanaka Y, Honda H, Ota Y, Shibata T, Sekiya M, Isobe T, Lamagna C, Masuda E, Iwama A, Shimano H, Inoue JI, Miyake K, Kitamura T. Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity. Nat Cardiovasc Res. 2024;3:1568\u201383. https:\/\/doi.org\/10.1038\/s44161-024-00579-w.","journal-title":"Nat Cardiovasc Res"},{"key":"1654_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03213-1","author":"M Diez-Diez","year":"2024","unstructured":"Diez-Diez M, Ramos-Neble BL, de la Barrera J, Silla-Castro JC, Quintas A, Vazquez E, Rey-Martin MA, Izzi B, Sanchez-Garcia L, Garcia-Lunar I, Mendieta G, Mass V, Gomez-Lopez N, Espadas C, Gonzalez G, Quesada AJ, Garcia-Alvarez A, Fernandez-Ortiz A, Lara-Pezzi E, Dopazo A, Sanchez-Cabo F, Ibanez B, Andres V, Fuster V, Fuster JJ. Unidirectional association of clonal hematopoiesis with atherosclerosis development. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03213-1.","journal-title":"Nat Med"},{"key":"1654_CR183","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.3390\/ijms24043962","volume":"24","author":"P Buttner","year":"2023","unstructured":"Buttner P, Bottner J, Krohn K, Baber R, Platzbecker U, Cross M, Desch S, Thiele H, Steiner S, Scheinert D, Metzeler KH, Branzan D. Clonal hematopoiesis mutations are present in atherosclerotic lesions in peripheral artery disease. Int J Mol Sci. 2023;24:3962. https:\/\/doi.org\/10.3390\/ijms24043962.","journal-title":"Int J Mol Sci"},{"key":"1654_CR184","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCRESAHA.118.311378","volume":"123","author":"Z Ungvari","year":"2018","unstructured":"Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849\u201367. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.311378.","journal-title":"Circ Res"},{"key":"1654_CR185","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jacc.2019.11.061","volume":"75","author":"Z Ungvari","year":"2020","unstructured":"Ungvari Z, Tarantini S, Sorond F, Merkely B, Csiszar A. Mechanisms of vascular aging, a geroscience perspective: JACC Focus Seminar. J Am Coll Cardiol. 2020;75:931\u201341. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.061.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR186","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1182\/bloodadvances.2024013228","volume":"8","author":"J Singh","year":"2024","unstructured":"Singh J, Li N, Ashrafi E, Thao LTP, Curtis DJ, Wood EM, McQuilten ZK. Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis. Blood Adv. 2024;8:3771\u201384. https:\/\/doi.org\/10.1182\/bloodadvances.2024013228.","journal-title":"Blood Adv"},{"key":"1654_CR187","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11883-023-01083-5","volume":"25","author":"AH Polizio","year":"2023","unstructured":"Polizio AH, Park E, Walsh K. Clonal hematopoiesis: connecting aging and inflammation in atherosclerosis. Curr Atheroscler Rep. 2023;25:105\u201311. https:\/\/doi.org\/10.1007\/s11883-023-01083-5.","journal-title":"Curr Atheroscler Rep"},{"key":"1654_CR188","doi-asserted-by":"publisher","unstructured":"von Scheidt M, Bauer S, Ma A, Hao K, Kessler T, Vilne B, Wang Y, Hodonsky CJ, Ghosh SKB, Mokry M, Gao H, Kawai K, Sakamoto A, Kaiser J, Bongiovanni D, Fleig J, Oldenbuettel L, Chen Z, Moggio A, Sager HB, Hecker JS, Bassermann F, Maegdefessel L, Miller CL, Koenig W, Zeiher AM, Dimmeler S, Graw M, Braun C, Ruusalepp A, et al. Leukocytes carrying clonal hematopoiesis of indeterminate potential (CHIP) mutations invade human atherosclerotic plaques. medRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.07.22.23292754","DOI":"10.1101\/2023.07.22.23292754"},{"key":"1654_CR189","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366:eaan4673. https:\/\/doi.org\/10.1126\/science.aan4673.","journal-title":"Science"},{"key":"1654_CR190","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","volume":"15","author":"V Hachinski","year":"2019","unstructured":"Hachinski V, Einhaupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C, Nishimura N, Schaffer CB, Whitehead SN, Black SE, Ostergaard L, Wardlaw J, Greenberg S, Friberg L, Norrving B, Rowe B, Joanette Y, Hacke W, Kuller L, Dichgans M, Endres M, Khachaturian ZS. Preventing dementia by preventing stroke: the Berlin Manifesto. Alzheimers Dement. 2019;15:961\u201384. https:\/\/doi.org\/10.1016\/j.jalz.2019.06.001.","journal-title":"Alzheimers Dement"},{"key":"1654_CR191","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42:2672\u2013713. https:\/\/doi.org\/10.1161\/STR.0b013e3182299496.","journal-title":"Stroke"},{"key":"1654_CR192","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1182\/blood.2022017661","volume":"141","author":"CM Arends","year":"2023","unstructured":"Arends CM, Liman TG, Strzelecka PM, Kufner A, Lowe P, Huo S, Stein CM, Piper SK, Tilgner M, Sperber PS, Dimitriou S, Heuschmann PU, Hablesreiter R, Harms C, Bullinger L, Weber JE, Endres M, Damm F. Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke. Blood. 2023;141:787\u201399. https:\/\/doi.org\/10.1182\/blood.2022017661.","journal-title":"Blood"},{"key":"1654_CR193","doi-asserted-by":"publisher","DOI":"10.5551\/jat.65056","author":"J Weng","year":"2024","unstructured":"Weng J, Qiu X, Jiang Y, Gu HQ, Meng X, Zhao X, Wang Y, Li Z. Impact of clonal hematopoiesis of indeterminate potential on the long-term risk of recurrent stroke in patients with a high atherosclerotic burden. J Atheroscler Thromb. 2024. https:\/\/doi.org\/10.5551\/jat.65056.","journal-title":"J Atheroscler Thromb"},{"key":"1654_CR194","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1182\/blood.2022019177","volume":"141","author":"N Wang","year":"2023","unstructured":"Wang N, Tall AR. Clonal hematopoiesis and ischemic stroke. Blood. 2023;141:693\u20134. https:\/\/doi.org\/10.1182\/blood.2022019177.","journal-title":"Blood"},{"key":"1654_CR195","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s40001-023-01566-w","volume":"28","author":"X Qiu","year":"2023","unstructured":"Qiu X, Weng J, Jiang Y, Cui L, Gu H, Jiang Y, Dai Y, Li H, Wang Y, Li Z. Association between clonal hematopoiesis-related gene mutations and unfavorable functional outcome in patients with large-artery atherosclerotic stroke. Eur J Med Res. 2023;28:599. https:\/\/doi.org\/10.1186\/s40001-023-01566-w.","journal-title":"Eur J Med Res"},{"key":"1654_CR196","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/STROKEAHA.122.041416","volume":"54","author":"E Mayerhofer","year":"2023","unstructured":"Mayerhofer E, Strecker C, Becker H, Georgakis MK, Uddin MM, Hoffmann MM, Nadarajah N, Meggendorfer M, Haferlach T, Rosand J, Natarajan P, Anderson CD, Harloff A, Hoermann G. Prevalence and therapeutic implications of clonal hematopoiesis of indeterminate potential in young patients with stroke. Stroke. 2023;54:938\u201346. https:\/\/doi.org\/10.1161\/STROKEAHA.122.041416.","journal-title":"Stroke"},{"key":"1654_CR197","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/ana.26754","volume":"94","author":"EJ Lee","year":"2023","unstructured":"Lee EJ, An HY, Lim J, Park KI, Choi SY, Jeong HY, Kang DW, Yang W, Kim JM, Ko SB, Lee SH, Yoon BW, Koh Y, Jung KH. Clonal hematopoiesis and acute ischemic stroke outcomes. Ann Neurol. 2023;94:836\u201347. https:\/\/doi.org\/10.1002\/ana.26754.","journal-title":"Ann Neurol"},{"key":"1654_CR198","doi-asserted-by":"publisher","first-page":"103964","DOI":"10.1016\/j.ebiom.2022.103964","volume":"78","author":"S Wang","year":"2022","unstructured":"Wang S, Hu S, Luo X, Bao X, Li J, Liu M, Lv Y, Zhao C, Zeng M, Chen X, Unsworth A, Jones S, Johnson TW, White SJ, Jia H, Yu B. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction. EBioMedicine. 2022;78:103964. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103964.","journal-title":"EBioMedicine"},{"key":"1654_CR199","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1182\/bloodadvances.2023011578","volume":"7","author":"J Woo","year":"2023","unstructured":"Woo J, Lu D, Lewandowski A, Xu H, Serrano P, Healey M, Yates DP, Beste MT, Libby P, Ridker PM, Steensma DP. Effects of IL-1beta inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial. Blood Adv. 2023;7:7471\u201384. https:\/\/doi.org\/10.1182\/bloodadvances.2023011578.","journal-title":"Blood Adv"},{"key":"1654_CR200","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson EC, Madar A, Campbell CD, He Y, Sultan M, Healey ML, Xu H, D\u2019Aco K, Fernandez A, Wache-Mainier C, Libby P, Ridker PM, Beste MT, Basson CT. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol. 2022;7:521\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2022.0386.","journal-title":"JAMA Cardiol"},{"key":"1654_CR201","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","volume":"4","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K, Schmid T, Br\u00fcne B, Wagner S, Serve H, Hoffmann J, Seeger F, Dimmeler S, Zeiher AM, Rieger MA. Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol. 2019;4:25\u201333. https:\/\/doi.org\/10.1001\/jamacardio.2018.3965.","journal-title":"JAMA Cardiol"},{"key":"1654_CR202","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","volume":"77","author":"DA Pascual-Figal","year":"2021","unstructured":"Pascual-Figal DA, Bayes-Genis A, D\u00edez-D\u00edez M, Hern\u00e1ndez-Vicente \u00c1, V\u00e1zquez-Andr\u00e9s D, de la Barrera J, Vazquez E, Quintas A, Zuriaga MA, Asensio-L\u00f3pez MC, Dopazo A, S\u00e1nchez-Cabo F, Fuster JJ. Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction. J Am Coll Cardiol. 2021;77:1747\u201359. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.028.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR203","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/eurheartj\/ehaa848","volume":"42","author":"MA Evans","year":"2021","unstructured":"Evans MA, Sano S, Walsh K. Clonal haematopoiesis and cardiovascular disease: how low can you go? Eur Heart J. 2021;42:266\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa848.","journal-title":"Eur Heart J"},{"key":"1654_CR204","doi-asserted-by":"publisher","first-page":"e003003","DOI":"10.1161\/circgen.120.003003","volume":"13","author":"S Cremer","year":"2020","unstructured":"Cremer S, Kirschbaum K, Berkowitsch A, John D, Kiefer K, Dorsheimer L, Wagner J, Rasper T, Abou-El-Ardat K, Assmus B, Serve H, Rieger M, Dimmeler S, Zeiher AM. Multiple somatic mutations for clonal hematopoiesis are associated with increased mortality in patients with chronic heart failure. Circ Genom Precis Med. 2020;13:e003003. https:\/\/doi.org\/10.1161\/circgen.120.003003.","journal-title":"Circ Genom Precis Med"},{"key":"1654_CR205","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2715","volume":"25","author":"C Shi","year":"2023","unstructured":"Shi C, Aboumsallem JP, Suthahar N, de Graaf AO, Jansen JH, van Zeventer IA, Bracun V, de Wit S, Screever EM, van den Berg PF, Meijers WC, Gansevoort RT, Bakker SJL, van der Harst P, Sillj\u00e9 HHW, Huls G, de Boer RA. Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers. Eur J Heart Fail. 2023;25:4\u201313. https:\/\/doi.org\/10.1002\/ejhf.2715.","journal-title":"Eur J Heart Fail"},{"key":"1654_CR206","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacc.2021.04.085","volume":"78","author":"B Yu","year":"2021","unstructured":"Yu B, Roberts MB, Raffield LM, Zekavat SM, Nguyen NQH, Biggs ML, Brown MR, Griffin G, Desai P, Correa A, Morrison AC, Shah AM, Niroula A, Uddin MM, Honigberg MC, Ebert BL, Psaty BM, Whitsel EA, Manson JE, Kooperberg C, Bick AG, Ballantyne CM, Reiner AP, Natarajan P, Eaton CB. Supplemental association of clonal hematopoiesis with incident heart failure. J Am Coll Cardiol. 2021;78:42\u201352. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.085.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR207","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3408","author":"FL Scolari","year":"2024","unstructured":"Scolari FL, Brahmbhatt D, Abelson S, Lee D, Kim RH, Pedarzadeh A, Sakhnini A, Adler A, Chan RH, Dick JE, Rakowski H, Billia F. Clonal haematopoiesis is associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy. Eur J Heart Fail. 2024. https:\/\/doi.org\/10.1002\/ejhf.3408.","journal-title":"Eur J Heart Fail"},{"key":"1654_CR208","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/eurheartj\/ehad869","volume":"45","author":"HJ Ahn","year":"2024","unstructured":"Ahn HJ, An HY, Ryu G, Lim J, Sun C, Song H, Choi SY, Lee H, Maurer T, Nachun D, Kwon S, Lee SR, Lip GYH, Oh S, Jaiswal S, Koh Y, Choi EK. Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study. Eur Heart J. 2024;45:778\u201390. https:\/\/doi.org\/10.1093\/eurheartj\/ehad869.","journal-title":"Eur Heart J"},{"key":"1654_CR209","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00395-016-0584-z","volume":"111","author":"Z Sun","year":"2016","unstructured":"Sun Z, Zhou D, Xie X, Wang S, Wang Z, Zhao W, Xu H, Zheng L. Cross-talk between macrophages and atrial myocytes in atrial fibrillation. Basic Res Cardiol. 2016;111:63. https:\/\/doi.org\/10.1007\/s00395-016-0584-z.","journal-title":"Basic Res Cardiol"},{"key":"1654_CR210","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jacc.2023.12.034","volume":"83","author":"S Ninni","year":"2024","unstructured":"Ninni S, Dombrowicz D, de Winther M, Staels B, Montaigne D, Nattel S. Genetic factors altering immune responses in atrial fibrillation JACC Review Topic of the Week. J Am Coll Cardiol. 2024;83:1163\u201376. https:\/\/doi.org\/10.1016\/j.jacc.2023.12.034.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR211","doi-asserted-by":"publisher","first-page":"e167517","DOI":"10.1172\/jci167517","volume":"133","author":"J Song","year":"2023","unstructured":"Song J, Navarro-Garcia JA, Wu J, Saljic A, Abu-Taha I, Li L, Lahiri SK, Keefe JA, Aguilar-Sanchez Y, Moore OM, Yuan Y, Wang X, Kamler M, Mitch WE, Ruiz-Hurtado G, Hu Z, Thomas SS, Dobrev D, Wehrens XH, Li N. Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation. J Clin Invest. 2023;133:e167517. https:\/\/doi.org\/10.1172\/jci167517.","journal-title":"J Clin Invest"},{"key":"1654_CR212","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","volume":"41","author":"S Mas-Peiro","year":"2020","unstructured":"Mas-Peiro S, Hoffmann J, Fichtlscherer S, Dorsheimer L, Rieger MA, Dimmeler S, Vasa-Nicotera M, Zeiher AM. Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur Heart J. 2020;41:933\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehz591.","journal-title":"Eur Heart J"},{"key":"1654_CR213","doi-asserted-by":"publisher","first-page":"e034255","DOI":"10.1161\/jaha.123.034255","volume":"13","author":"S Ninni","year":"2024","unstructured":"Ninni S, Vicario R, Coisne A, Woitrain E, Tazibet A, Stewart CM, Diaz LA Jr, White JR, Koussa M, Dubrulle H, Juthier F, Jungling M, Vincentelli A, Edme JL, Nattel S, de Winther M, Geissmann F, Dombrowicz D, Staels B, Montaigne D. Clonal hematopoiesis is associated with long-term adverse outcomes following cardiac surgery. J Am Heart Assoc. 2024;13:e034255. https:\/\/doi.org\/10.1161\/jaha.123.034255.","journal-title":"J Am Heart Assoc"},{"key":"1654_CR214","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/ejhf.2588","volume":"24","author":"FL Scolari","year":"2022","unstructured":"Scolari FL, Abelson S, Brahmbhatt DH, Medeiros JJF, Fan CS, Fung NL, Mihajlovic V, Anker MS, Otsuki M, Lawler PR, Ross HJ, Luk AC, Anker S, Dick JE, Billia F. Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock. Eur J Heart Fail. 2022;24:1573\u201382. https:\/\/doi.org\/10.1002\/ejhf.2588.","journal-title":"Eur J Heart Fail"},{"key":"1654_CR215","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jacc.2022.08.740","volume":"80","author":"M Bohme","year":"2022","unstructured":"Bohme M, Desch S, Rosolowski M, Scholz M, Krohn K, Buttner P, Cross M, Kirchberg J, Rommel KP, Poss J, Freund A, Baber R, Isermann B, Ceglarek U, Metzeler KH, Platzbecker U, Thiele H. Impact of clonal hematopoiesis in patients with cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2022;80:1545\u201356. https:\/\/doi.org\/10.1016\/j.jacc.2022.08.740.","journal-title":"J Am Coll Cardiol"},{"key":"1654_CR216","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","volume":"92","author":"RJ Cannistraro","year":"2019","unstructured":"Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: a clinical review. Neurology. 2019;92:1146\u201356. https:\/\/doi.org\/10.1212\/WNL.0000000000007654.","journal-title":"Neurology"},{"key":"1654_CR217","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00415-015-7776-6","volume":"262","author":"D Pinter","year":"2015","unstructured":"Pinter D, Enzinger C, Fazekas F. Cerebral small vessel disease, cognitive reserve and cognitive dysfunction. J Neurol. 2015;262:2411\u20139. https:\/\/doi.org\/10.1007\/s00415-015-7776-6.","journal-title":"J Neurol"},{"key":"1654_CR218","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1161\/01.STR.0000179092.59909.42","volume":"36","author":"WM van der Flier","year":"2005","unstructured":"van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36:2116\u201320. https:\/\/doi.org\/10.1161\/01.STR.0000179092.59909.42.","journal-title":"Stroke"},{"key":"1654_CR219","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev-physiol-060821-014521","volume":"84","author":"JM Wardlaw","year":"2022","unstructured":"Wardlaw JM, Benveniste H, Williams A. Cerebral vascular dysfunctions detected in human small vessel disease and implications for preclinical studies. Annu Rev Physiol. 2022;84:409\u201334. https:\/\/doi.org\/10.1146\/annurev-physiol-060821-014521.","journal-title":"Annu Rev Physiol"},{"key":"1654_CR220","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.123.19943","volume":"81","author":"AH Hainsworth","year":"2024","unstructured":"Hainsworth AH, Markus HS, Schneider JA. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia. Hypertension. 2024;81:75\u201386. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.19943.","journal-title":"Hypertension"},{"key":"1654_CR221","doi-asserted-by":"publisher","DOI":"10.2337\/db24-0841","author":"J Wei","year":"2025","unstructured":"Wei J, Yu Y, Wu H, Li Y, Wang N, Tan X. Clonal haematopoiesis of indeterminate potential and risk of microvascular complications among individuals with type 2 diabetes: a cohort study. Diabetes. 2025. https:\/\/doi.org\/10.2337\/db24-0841.","journal-title":"Diabetes"},{"key":"1654_CR222","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.3390\/jcm13206084","volume":"13","author":"AI Schafer","year":"2024","unstructured":"Schafer AI, Mann DL. Thrombotic, cardiovascular, and microvascular complications of myeloproliferative neoplasms and clonal hematopoiesis (CHIP): a narrative review. J Clin Med. 2024;13:6084. https:\/\/doi.org\/10.3390\/jcm13206084.","journal-title":"J Clin Med"},{"key":"1654_CR223","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1161\/ATVBAHA.123.319197","volume":"43","author":"J Cochran","year":"2023","unstructured":"Cochran J, Walsh K. Clonal hematopoiesis: from macrovascular to microvascular disease. Arterioscler Thromb Vasc Biol. 2023;43:784\u20136. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319197.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1654_CR224","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/ATVBAHA.122.318928","volume":"43","author":"N Akhiyat","year":"2023","unstructured":"Akhiyat N, Lasho T, Ganji M, Toya T, Shi CX, Chen X, Braggio E, Ahmad A, Corban MT, Stewart K, Fernandez J, Xie Z, Finke C, Lerman LO, Patnaik MM, Lerman A. Clonal hematopoiesis of indeterminate potential is associated with coronary microvascular dysfunction in early nonobstructive coronary artery disease. Arterioscler Thromb Vasc Biol. 2023;43:774\u201383. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318928.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1654_CR225","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/STROKEAHA.121.037678","volume":"53","author":"T Hirano","year":"2022","unstructured":"Hirano T, Kasner SE. Stranger than fiction, clonal hematopoiesis of indeterminate potential, and small vessel pathology. Stroke. 2022;53:798\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.121.037678.","journal-title":"Stroke"},{"key":"1654_CR226","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/17474930221144911","volume":"18","author":"HS Markus","year":"2023","unstructured":"Markus HS, de Leeuw FE. Cerebral small vessel disease: recent advances and future directions. Int J Stroke. 2023;18:4\u201314. https:\/\/doi.org\/10.1177\/17474930221144911.","journal-title":"Int J Stroke"},{"key":"1654_CR227","doi-asserted-by":"publisher","first-page":"843953","DOI":"10.3389\/fneur.2022.843953","volume":"13","author":"B Ren","year":"2022","unstructured":"Ren B, Tan L, Song Y, Li D, Xue B, Lai X, Gao Y. Cerebral small vessel disease: neuroimaging features, biochemical markers, influencing factors, pathological mechanism and treatment. Front Neurol. 2022;13:843953. https:\/\/doi.org\/10.3389\/fneur.2022.843953.","journal-title":"Front Neurol"},{"key":"1654_CR228","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00415-018-9077-3","volume":"266","author":"X Chen","year":"2019","unstructured":"Chen X, Wang J, Shan Y, Cai W, Liu S, Hu M, Liao S, Huang X, Zhang B, Wang Y, Lu Z. Cerebral small vessel disease: neuroimaging markers and clinical implication. J Neurol. 2019;266:2347\u201362. https:\/\/doi.org\/10.1007\/s00415-018-9077-3.","journal-title":"J Neurol"},{"key":"1654_CR229","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701. https:\/\/doi.org\/10.1016\/S1474-4422(10)70104-6.","journal-title":"Lancet Neurol"},{"key":"1654_CR230","doi-asserted-by":"publisher","first-page":"109236","DOI":"10.1016\/j.thromres.2024.109236","volume":"245","author":"MH Kristiansen","year":"2025","unstructured":"Kristiansen MH, Larsen MK, Massarenti L, Skov V, Kjaer L, Enevold C, Ostrowski SR, Nielsen CH, Hasselbalch HC, Wienecke T. Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutation. Thromb Res. 2025;245:109236. https:\/\/doi.org\/10.1016\/j.thromres.2024.109236.","journal-title":"Thromb Res"},{"key":"1654_CR231","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/bpa.12177","volume":"24","author":"LJ Craggs","year":"2014","unstructured":"Craggs LJ, Yamamoto Y, Deramecourt V, Kalaria RN. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain. Brain Pathol. 2014;24:495\u2013509. https:\/\/doi.org\/10.1111\/bpa.12177.","journal-title":"Brain Pathol"},{"key":"1654_CR232","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp.2009.204685","volume":"82","author":"AA Gouw","year":"2011","unstructured":"Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011;82:126\u201335. https:\/\/doi.org\/10.1136\/jnnp.2009.204685.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1654_CR233","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1177\/0271678X16662891","volume":"36","author":"Y Shi","year":"2016","unstructured":"Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, van Buchem MA, Wardlaw JM. Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2016;36:1653\u201367. https:\/\/doi.org\/10.1177\/0271678X16662891.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1654_CR234","doi-asserted-by":"publisher","first-page":"103165","DOI":"10.1016\/j.nicl.2022.103165","volume":"36","author":"W Lu","year":"2022","unstructured":"Lu W, Yu C, Wang L, Wang F, Qiu J. Perfusion heterogeneity of cerebral small vessel disease revealed via arterial spin labeling MRI and machine learning. Neuroimage Clin. 2022;36:103165. https:\/\/doi.org\/10.1016\/j.nicl.2022.103165.","journal-title":"Neuroimage Clin"},{"key":"1654_CR235","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3174\/ajnr.A7630","volume":"43","author":"B Gyanwali","year":"2022","unstructured":"Gyanwali B, Tan CS, Petr J, Escobosa LLT, Vrooman H, Chen C, Mutsaerts HJ, Hilal S. Arterial spin-labeling parameters and their associations with risk factors, cerebral small-vessel disease, and etiologic subtypes of cognitive impairment and dementia. AJNR Am J Neuroradiol. 2022;43:1418\u201323. https:\/\/doi.org\/10.3174\/ajnr.A7630.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1654_CR236","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal DR, Ghebremedhin E, Orantes M, Wiestler OD. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol. 2003;62:1287\u2013301. https:\/\/doi.org\/10.1093\/jnen\/62.12.1287.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1654_CR237","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1590\/s0004-282x2009000100020","volume":"67","author":"MR Andrade","year":"2009","unstructured":"Andrade MR, Pittella JE. Immunohistochemical identification of plasma protein deposits in the wall of lenticulostriate arteries in patients with long-standing hypertension, with and without lipohyalinosis. Arq Neuropsiquiatr. 2009;67:82\u20139. https:\/\/doi.org\/10.1590\/s0004-282x2009000100020.","journal-title":"Arq Neuropsiquiatr"},{"key":"1654_CR238","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2022.12.003","volume":"254","author":"LB Eisenmenger","year":"2023","unstructured":"Eisenmenger LB, Peret A, Famakin BM, Spahic A, Roberts GS, Bockholt JH, Johnson KM, Paulsen JS. Vascular contributions to Alzheimer\u2019s disease. Transl Res. 2023;254:41\u201353. https:\/\/doi.org\/10.1016\/j.trsl.2022.12.003.","journal-title":"Transl Res"},{"key":"1654_CR239","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","volume":"70","author":"A Viswanathan","year":"2011","unstructured":"Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70:871\u201380. https:\/\/doi.org\/10.1002\/ana.22516.","journal-title":"Ann Neurol"},{"key":"1654_CR240","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","volume":"22","author":"EA Koemans","year":"2023","unstructured":"Koemans EA, Chhatwal JP, van Veluw SJ, van Etten ES, van Osch MJP, van Walderveen MAA, Sohrabi HR, Kozberg MG, Shirzadi Z, Terwindt GM, van Buchem MA, Smith EE, Werring DJ, Martins RN, Wermer MJH, Greenberg SM. Progression of cerebral amyloid angiopathy: a pathophysiological framework. Lancet Neurol. 2023;22:632\u201342. https:\/\/doi.org\/10.1016\/S1474-4422(23)00114-X.","journal-title":"Lancet Neurol"},{"key":"1654_CR241","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11357-021-00493-0","volume":"44","author":"M van Dinther","year":"2022","unstructured":"van Dinther M, Schram MT, Jansen JFA, Backes WH, Houben A, Berendschot T, Schalkwijk CG, Stehouwer CDA, van Oostenbrugge RJ, Staals J. Extracerebral microvascular dysfunction is related to brain MRI markers of cerebral small vessel disease: the Maastricht Study. Geroscience. 2022;44:147\u201357. https:\/\/doi.org\/10.1007\/s11357-021-00493-0.","journal-title":"Geroscience"},{"key":"1654_CR242","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tins.2020.11.003","volume":"44","author":"S Quick","year":"2021","unstructured":"Quick S, Moss J, Rajani RM, Williams A. A vessel for change: endothelial dysfunction in cerebral small vessel disease. Trends Neurosci. 2021;44:289\u2013305. https:\/\/doi.org\/10.1016\/j.tins.2020.11.003.","journal-title":"Trends Neurosci"},{"key":"1654_CR243","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/hr.2015.4","volume":"38","author":"T Nezu","year":"2015","unstructured":"Nezu T, Hosomi N, Aoki S, Kubo S, Araki M, Mukai T, Takahashi T, Maruyama H, Higashi Y, Matsumoto M. Endothelial dysfunction is associated with the severity of cerebral small vessel disease. Hypertens Res. 2015;38:291\u20137. https:\/\/doi.org\/10.1038\/hr.2015.4.","journal-title":"Hypertens Res"},{"key":"1654_CR244","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.14670\/HH-18-792","volume":"39","author":"MR Hayden","year":"2024","unstructured":"Hayden MR. Brain endothelial cell activation and dysfunction associate with and contribute to the development of enlarged perivascular spaces and cerebral small vessel disease. Histol Histopathol. 2024;39:1565\u201386. https:\/\/doi.org\/10.14670\/HH-18-792.","journal-title":"Histol Histopathol"},{"key":"1654_CR245","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2396987318805905","volume":"4","author":"F Arba","year":"2019","unstructured":"Arba F, Giannini A, Piccardi B, Biagini S, Palumbo V, Giusti B, Nencini P, Maria Gori A, Nesi M, Pracucci G, Bono G, Bovi P, Fainardi E, Consoli D, Nucera A, Massaro F, Orlandi G, Perini F, Tassi R, Sessa M, Toni D, Abbate R, Inzitari D. Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke. Eur Stroke J. 2019;4:119\u201326. https:\/\/doi.org\/10.1177\/2396987318805905.","journal-title":"Eur Stroke J"},{"key":"1654_CR246","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","volume":"17","author":"Z Ungvari","year":"2021","unstructured":"Ungvari Z, Toth P, Tarantini S, Prodan CI, Sorond F, Merkely B, Csiszar A. Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17:639\u201354. https:\/\/doi.org\/10.1038\/s41581-021-00430-6.","journal-title":"Nat Rev Nephrol"},{"key":"1654_CR247","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18:684\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(19)30079-1.","journal-title":"Lancet Neurol"},{"key":"1654_CR248","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","volume":"15","author":"MJ Thrippleton","year":"2019","unstructured":"Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJP, Dichgans M, Fazekas F, Ropele S, Frayne R, van Oostenbrugge RJ, Smith EE, Wardlaw JM. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement. 2019;15:840\u201358. https:\/\/doi.org\/10.1016\/j.jalz.2019.01.013.","journal-title":"Alzheimers Dement"},{"key":"1654_CR249","doi-asserted-by":"publisher","unstructured":"Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178\u2013201. S0896\u20136273(08)00034\u20132 [pii]. https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003","DOI":"10.1016\/j.neuron.2008.01.003"},{"key":"1654_CR250","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017.","journal-title":"Physiol Rev"},{"key":"1654_CR251","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350. https:\/\/doi.org\/10.1038\/nrneurol.2017.188.","journal-title":"Nat Rev Neurol"},{"key":"1654_CR252","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV. The role of brain vasculature in neurodegenerative disorders. Nat Neurosci. 2018;21:1318\u201331. https:\/\/doi.org\/10.1038\/s41593-018-0234-x.","journal-title":"Nat Neurosci"},{"key":"1654_CR253","doi-asserted-by":"publisher","first-page":"H1128","DOI":"10.1152\/ajpheart.00780.2016","volume":"312","author":"Z Ungvari","year":"2017","unstructured":"Ungvari Z, Tarantini S, Kirkpatrick AC, Csiszar A, Prodan CI. Cerebral microhemorrhages: mechanisms, consequences, and prevention. Am J Physiol Heart Circ Physiol. 2017;312:H1128\u201343. https:\/\/doi.org\/10.1152\/ajpheart.00780.2016.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1654_CR254","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S1474-4422(17)30196-5","volume":"16","author":"SJ van Veluw","year":"2017","unstructured":"van Veluw SJ, Shih AY, Smith EE, Chen C, Schneider JA, Wardlaw JM, Greenberg SM, Biessels GJ. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol. 2017;16:730\u201340. https:\/\/doi.org\/10.1016\/S1474-4422(17)30196-5.","journal-title":"Lancet Neurol"},{"key":"1654_CR255","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ana.25512","volume":"86","author":"SJ van Veluw","year":"2019","unstructured":"van Veluw SJ, Scherlek AA, Freeze WM, Ter Telgte A, van der Kouwe AJ, Bacskai BJ, Frosch MP, Greenberg SM. Different microvascular alterations underlie microbleeds and microinfarcts. Ann Neurol. 2019;86:279\u201392. https:\/\/doi.org\/10.1002\/ana.25512.","journal-title":"Ann Neurol"},{"key":"1654_CR256","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.jalz.2014.12.010","volume":"11","author":"SJ van Veluw","year":"2015","unstructured":"van Veluw SJ, Hilal S, Kuijf HJ, Ikram MK, Xin X, Yeow TB, Venketasubramanian N, Biessels GJ, Chen C. Cortical microinfarcts on 3T MRI: clinical correlates in memory-clinic patients. Alzheimers Dement. 2015;11:1500\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2014.12.010.","journal-title":"Alzheimers Dement"},{"key":"1654_CR257","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S1474-4422(11)70307-6","volume":"11","author":"EE Smith","year":"2012","unstructured":"Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012;11:272\u201382. https:\/\/doi.org\/10.1016\/S1474-4422(11)70307-6.","journal-title":"Lancet Neurol"},{"key":"1654_CR258","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000371488.000371488[pii]","volume":"39","author":"JL De Reuck","year":"2015","unstructured":"De Reuck JL, Deramecourt V, Auger F, Durieux N, Cordonnier C, Devos D, Defebvre L, Moreau C, Capparos-Lefebvre D, Pasquier F, Leys D, Maurage CA, Bordet R. The significance of cortical cerebellar microbleeds and microinfarcts in neurodegenerative and cerebrovascular diseases. A post-mortem 7.0-tesla magnetic resonance study with neuropathological correlates. Cerebrovasc Dis. 2015;39:138\u201343. https:\/\/doi.org\/10.1159\/000371488.000371488[pii].","journal-title":"Cerebrovasc Dis"},{"key":"1654_CR259","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/jcbfm.2011.200","volume":"32","author":"M Brundel","year":"2012","unstructured":"Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab. 2012;32:425\u201336. https:\/\/doi.org\/10.1038\/jcbfm.2011.200.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1654_CR260","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/STROKEAHA.110.595082","volume":"42","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011;42:722\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.110.595082.","journal-title":"Stroke"},{"key":"1654_CR261","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jmri.28989","volume":"59","author":"PHM Voorter","year":"2024","unstructured":"Voorter PHM, van Dinther M, Jansen WJ, Postma AA, Staals J, Jansen JFA, van Oostenbrugge RJ, van der Thiel MM, Backes WH. Blood-brain barrier disruption and perivascular spaces in small vessel disease and neurodegenerative diseases: a review on MRI methods and insights. J Magn Reson Imaging. 2024;59:397\u2013411. https:\/\/doi.org\/10.1002\/jmri.28989.","journal-title":"J Magn Reson Imaging"},{"key":"1654_CR262","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/17474930221091879","volume":"18","author":"H van den Brink","year":"2023","unstructured":"van den Brink H, Doubal FN, Duering M. Advanced MRI in cerebral small vessel disease. Int J Stroke. 2023;18:28\u201335. https:\/\/doi.org\/10.1177\/17474930221091879.","journal-title":"Int J Stroke"},{"key":"1654_CR263","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1161\/STROKEAHA.117.016996","volume":"48","author":"JJM Zwanenburg","year":"2017","unstructured":"Zwanenburg JJM, van Osch MJP. Targeting cerebral small vessel disease with MRI. Stroke. 2017;48:3175\u201382. https:\/\/doi.org\/10.1161\/STROKEAHA.117.016996.","journal-title":"Stroke"},{"key":"1654_CR264","doi-asserted-by":"publisher","first-page":"e030351","DOI":"10.1161\/JAHA.123.030351","volume":"12","author":"N Karvelas","year":"2023","unstructured":"Karvelas N, Elahi FM. White matter hyperintensities: complex predictor of complex outcomes. J Am Heart Assoc. 2023;12:e030351. https:\/\/doi.org\/10.1161\/JAHA.123.030351.","journal-title":"J Am Heart Assoc"},{"key":"1654_CR265","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1212\/WNL.0000000000200782","volume":"99","author":"V Lohner","year":"2022","unstructured":"Lohner V, Pehlivan G, Sanroma G, Miloschewski A, Schirmer MD, Stocker T, Reuter M, Breteler MMB. Relation between sex, menopause, and white matter hyperintensities: the Rhineland Study. Neurology. 2022;99:e935\u201343. https:\/\/doi.org\/10.1212\/WNL.0000000000200782.","journal-title":"Neurology"},{"key":"1654_CR266","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.neuroimage.2011.08.059","volume":"59","author":"MM Conijn","year":"2012","unstructured":"Conijn MM, Hoogduin JM, van der Graaf Y, Hendrikse J, Luijten PR, Geerlings MI. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity \u2013 a 7 T study. Neuroimage. 2012;59:950\u20136. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.08.059.","journal-title":"Neuroimage"},{"key":"1654_CR267","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/brainsci13091323","volume":"13","author":"F Rodriguez Lara","year":"2023","unstructured":"Rodriguez Lara F, Toro AR, Pinheiro A, Demissie S, Ekenze O, Martinez O, Parva P, Charidimou A, Ghosh S, DeCarli C, Seshadri S, Habes M, Maillard P, Romero JR. Relation of MRI-visible perivascular spaces and other MRI markers of cerebral small vessel disease. Brain Sci. 2023;13:1323. https:\/\/doi.org\/10.3390\/brainsci13091323.","journal-title":"Brain Sci"},{"key":"1654_CR268","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1212\/WNL.0000000000201447","volume":"100","author":"HS Markus","year":"2023","unstructured":"Markus HS. Perivascular spaces: an exciting research frontier in cerebral small vessel disease. Neurology. 2023;100:53\u20134. https:\/\/doi.org\/10.1212\/WNL.0000000000201447.","journal-title":"Neurology"},{"key":"1654_CR269","doi-asserted-by":"publisher","first-page":"e209306","DOI":"10.1212\/WNL.0000000000209306","volume":"102","author":"H Li","year":"2024","unstructured":"Li H, Jacob MA, Cai M, Kessels RPC, Norris DG, Duering M, De Leeuw FE, Tuladhar AM. Perivascular spaces, diffusivity along perivascular spaces, and free water in cerebral small vessel disease. Neurology. 2024;102:e209306. https:\/\/doi.org\/10.1212\/WNL.0000000000209306.","journal-title":"Neurology"},{"key":"1654_CR270","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/STROKEAHA.123.045857","volume":"55","author":"H Hong","year":"2024","unstructured":"Hong H, Tozer DJ, Markus HS. Relationship of perivascular space markers with incident dementia in cerebral small vessel disease. Stroke. 2024;55:1032\u201340. https:\/\/doi.org\/10.1161\/STROKEAHA.123.045857.","journal-title":"Stroke"},{"key":"1654_CR271","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae357","author":"H Hong","year":"2024","unstructured":"Hong H, Tozer D, Chen Y, Brown R, Low A, Markus HS. Perivascular space dysfunction in cerebral small vessel disease is related to neuroinflammation. Brain. 2024. https:\/\/doi.org\/10.1093\/brain\/awae357.","journal-title":"Brain"},{"key":"1654_CR272","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1152\/ajpheart.00581.2016","volume":"312","author":"P Toth","year":"2017","unstructured":"Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312:H1\u201320. https:\/\/doi.org\/10.1152\/ajpheart.00581.2016.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1654_CR273","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1002\/alz.14072","volume":"20","author":"CD Owens","year":"2024","unstructured":"Owens CD, Pinto CB, Mukli P, Gulej R, Velez FS, Detwiler S, Olay L, Hoffmeister JR, Szarvas Z, Muranyi M, Peterfi A, Pinaffi-Langley A, Adams C, Sharps J, Kaposzta Z, Prodan CI, Kirkpatrick AC, Tarantini S, Csiszar A, Ungvari Z, Olson AL, Li G, Balasubramanian P, Galvan V, Bauer A, Smith ZA, Dasari TW, Whitehead S, Medapti MR, Elahi FM, et al. Neurovascular coupling, functional connectivity, and cerebrovascular endothelial extracellular vesicles as biomarkers of mild cognitive impairment. Alzheimers Dement. 2024;20:5590\u2013606. https:\/\/doi.org\/10.1002\/alz.14072.","journal-title":"Alzheimers Dement"},{"key":"1654_CR274","doi-asserted-by":"publisher","first-page":"H299","DOI":"10.1152\/ajpheart.00744.2013","volume":"306","author":"P Toth","year":"2014","unstructured":"Toth P, Tarantini S, Tucsek Z, Ashpole NM, Sosnowska D, Gautam T, Ballabh P, Koller A, Sonntag WE, Csiszar A, Ungvari ZI. Resveratrol treatment rescues neurovascular coupling in aged mice:role of improved cerebromicrovascular endothelial function and down-regulation of NADPH oxidas. Am J Physiol Heart Circ Physiol. 2014;306:H299-308. https:\/\/doi.org\/10.1152\/ajpheart.00744.2013.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1654_CR275","doi-asserted-by":"publisher","first-page":"e12731","DOI":"10.1111\/acel.12731","volume":"17","author":"S Tarantini","year":"2018","unstructured":"Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Fulop GA, Hertelendy P, Gautam T, Farkas E, Perz A, Rabinovitch PS, Sonntag WE, Csiszar A, Ungvari Z. Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice. Aging Cell. 2018;17:e12731. https:\/\/doi.org\/10.1111\/acel.12731.","journal-title":"Aging Cell"},{"key":"1654_CR276","doi-asserted-by":"publisher","first-page":"101192","DOI":"10.1016\/j.redox.2019.101192","volume":"24","author":"S Tarantini","year":"2019","unstructured":"Tarantini S, Valcarcel-Ares MN, Toth P, Yabluchanskiy A, Tucsek Z, Kiss T, Hertelendy P, Kinter M, Ballabh P, Sule Z, Farkas E, Baur JA, Sinclair DA, Csiszar A, Ungvari Z. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox Biol. 2019;24:101192. https:\/\/doi.org\/10.1016\/j.redox.2019.101192.","journal-title":"Redox Biol"},{"key":"1654_CR277","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.exger.2016.11.004","volume":"94","author":"S Tarantini","year":"2017","unstructured":"Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A. Impaired neurovascular coupling in aging and Alzheimer\u2019s disease: contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp Gerontol. 2017;94:52\u20138. https:\/\/doi.org\/10.1016\/j.exger.2016.11.004.","journal-title":"Exp Gerontol"},{"key":"1654_CR278","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11:157\u201365. https:\/\/doi.org\/10.1038\/nrneurol.2015.10.","journal-title":"Nat Rev Neurol"},{"key":"1654_CR279","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1468-1331.2012.03785.x","volume":"20","author":"I Makedonov","year":"2013","unstructured":"Makedonov I, Black SE, MacIntosh BJ. Cerebral small vessel disease in aging and Alzheimer\u2019s disease: a comparative study using MRI and SPECT. Eur J Neurol. 2013;20:243\u201350. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03785.x.","journal-title":"Eur J Neurol"},{"key":"1654_CR280","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/brain\/awac265","volume":"146","author":"A Dewenter","year":"2023","unstructured":"Dewenter A, Jacob MA, Cai M, Gesierich B, Hager P, Kopczak A, Biel D, Ewers M, Tuladhar AM, de Leeuw FE, Dichgans M, Franzmeier N, Duering M. Consortium SVt, Alzheimer\u2019s disease neuroimaging I. Disentangling the effects of Alzheimer\u2019s and small vessel disease on white matter fibre tracts. Brain. 2023;146:678\u201389. https:\/\/doi.org\/10.1093\/brain\/awac265.","journal-title":"Brain"},{"key":"1654_CR281","doi-asserted-by":"publisher","unstructured":"Castillo-Carranza DL, Nilson AN, Van Skike CE, Jahrling JB, Patel K, Garach P, Gerson JE, Sengupta U, Abisambra J, Nelson P, Troncoso J, Ungvari Z, Galvan V, Kayed R. Cerebral microvascular accumulation of tau oligomers in Alzheimer\u2019s disease and related tauopathies. Aging Dis. 2017;8:257\u2013266. ad-8\u20133\u2013257 [pii]. https:\/\/doi.org\/10.14336\/AD.2017.0112.","DOI":"10.14336\/AD.2017.0112"},{"key":"1654_CR282","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3233\/JAD-221209","volume":"94","author":"L Edwards","year":"2023","unstructured":"Edwards L, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Walker KS, Brenner EK, Nation DA, Maillard P, Bondi MW, Bangen KJ. Alzheimer\u2019s disease neuroimaging I. White matter hyperintensity volume and amyloid-PET synergistically impact memory independent of Tau-PET in older adults without dementia. J Alzheimers Dis. 2023;94:695\u2013707. https:\/\/doi.org\/10.3233\/JAD-221209.","journal-title":"J Alzheimers Dis"},{"key":"1654_CR283","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00616.2021","author":"CD Owens","year":"2022","unstructured":"Owens CD, Mukli P, Csipo T, Lipecz A, Silva-Palacios F, Dasari TW, Tarantini S, Gardner AW, Montgomery PS, Waldstein SR, Kellawan JM, Nyul-Toth A, Balasubramanian P, Sotonyi P, Csiszar A, Ungvari Z, Yabluchanskiy A. Microvascular dysfunction and neurovascular uncoupling are exacerbated in peripheral artery disease, increasing the risk of cognitive decline in older adults. Am J Physiol Heart Circ Physiol. 2022. https:\/\/doi.org\/10.1152\/ajpheart.00616.2021.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1654_CR284","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr, Garcia-Cardena G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118:620\u201336. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306301.","journal-title":"Circ Res"},{"key":"1654_CR285","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00109-010-0667-5","volume":"88","author":"Z Ungvari","year":"2010","unstructured":"Ungvari Z, Sonntag WE, Csiszar A. Mitochondria and aging in the vascular system. J Mol Med (Berl). 2010;88:1021\u20137. https:\/\/doi.org\/10.1007\/s00109-010-0667-5.","journal-title":"J Mol Med (Berl)"},{"key":"1654_CR286","doi-asserted-by":"publisher","unstructured":"Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res. 2012;110:1109\u20131124. 110\/8\/1109 [pii]. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.246140.","DOI":"10.1161\/CIRCRESAHA.111.246140"},{"key":"1654_CR287","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1093\/gerona\/glq113","volume":"65","author":"Z Ungvari","year":"2010","unstructured":"Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010;65:1028\u201341. https:\/\/doi.org\/10.1093\/gerona\/glq113.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1654_CR288","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20:589\u2013610. https:\/\/doi.org\/10.1038\/s41573-021-00198-1.","journal-title":"Nat Rev Drug Discov"},{"key":"1654_CR289","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1212\/WNL.0000000000001279","volume":"84","author":"A Shoamanesh","year":"2015","unstructured":"Shoamanesh A, Preis SR, Beiser AS, Vasan RS, Benjamin EJ, Kase CS, Wolf PA, DeCarli C, Romero JR, Seshadri S. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology. 2015;84:825\u201332. https:\/\/doi.org\/10.1212\/WNL.0000000000001279.","journal-title":"Neurology"},{"key":"1654_CR290","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood.2023022222","volume":"142","author":"LD Weeks","year":"2023","unstructured":"Weeks LD, Ebert BL. Causes and consequences of clonal hematopoiesis. Blood. 2023;142:2235\u201346. https:\/\/doi.org\/10.1182\/blood.2023022222.","journal-title":"Blood"},{"key":"1654_CR291","doi-asserted-by":"publisher","first-page":"132184","DOI":"10.1016\/j.ijcard.2024.132184","volume":"409","author":"R Molinaro","year":"2024","unstructured":"Molinaro R, Sellar RS, Vromman A, Sausen G, Folco E, Sukhova GK, McConke ME, Corbo C, Ebert BL, Libby P. The clonal hematopoiesis mutation Jak 2(V617F) aggravates endothelial injury and thrombosis in arteries with erosion-like intimas. Int J Cardiol. 2024;409:132184. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132184.","journal-title":"Int J Cardiol"},{"key":"1654_CR292","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12967-022-03354-2","volume":"20","author":"T Xing","year":"2022","unstructured":"Xing T, Lyu ZS, Duan CW, Zhao HY, Tang SQ, Wen Q, Zhang YY, Lv M, Wang Y, Xu LP, Zhang XH, Huang XJ, Kong Y. Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes. J Transl Med. 2022;20:144. https:\/\/doi.org\/10.1186\/s12967-022-03354-2.","journal-title":"J Transl Med"},{"key":"1654_CR293","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/01.Res.0000115557.25127.8d","volume":"94","author":"S Wassmann","year":"2004","unstructured":"Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, B\u00f6hm M, Nickenig G. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534\u201341. https:\/\/doi.org\/10.1161\/01.Res.0000115557.25127.8d.","journal-title":"Circ Res"},{"key":"1654_CR294","doi-asserted-by":"publisher","first-page":"30057","DOI":"10.1074\/jbc.M606279200","volume":"281","author":"M Saura","year":"2006","unstructured":"Saura M, Zaragoza C, Bao C, Herranz B, Rodriguez-Puyol M, Lowenstein CJ. Stat3 mediates interleukin-6 [correction of interelukin-6] inhibition of human endothelial nitric-oxide synthase expression. J Biol Chem. 2006;281:30057\u201362. https:\/\/doi.org\/10.1074\/jbc.M606279200.","journal-title":"J Biol Chem"},{"key":"1654_CR295","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/19714009211002778","volume":"34","author":"N Mokhber","year":"2021","unstructured":"Mokhber N, Shariatzadeh A, Avan A, Saber H, Babaei GS, Chaimowitz G, Azarpazhooh MR. Cerebral blood flow changes during aging process and in cognitive disorders: a review. Neuroradiol J. 2021;34:300\u20137. https:\/\/doi.org\/10.1177\/19714009211002778.","journal-title":"Neuroradiol J"},{"key":"1654_CR296","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2353\/ajpath.2007.060708","volume":"170","author":"A Csiszar","year":"2007","unstructured":"Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z. Vasculoprotective effects of anti-TNFalfa treatment in aging. Am J Pathol. 2007;170:388\u2013698.","journal-title":"Am J Pathol"},{"key":"1654_CR297","doi-asserted-by":"publisher","first-page":"284","DOI":"10.14336\/AD.2021.0617","volume":"13","author":"A Romero","year":"2022","unstructured":"Romero A, Dongil P, Valencia I, Vallejo S, Hipolito-Luengo AS, Diaz-Araya G, Bartha JL, Gonzalez-Arlanzon MM, Rivilla F, de la Cuesta F, Sanchez-Ferrer CF, Peiro C. Pharmacological blockade of NLRP3 inflammasome\/IL-1beta-positive loop mitigates endothelial cell senescence and dysfunction. Aging Dis. 2022;13:284\u201397. https:\/\/doi.org\/10.14336\/AD.2021.0617.","journal-title":"Aging Dis"},{"key":"1654_CR298","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jvs.2010.01.088","volume":"52","author":"AL Stoica","year":"2010","unstructured":"Stoica AL, Stoica E, Constantinescu I, Uscatescu V, Ginghina C. Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. J Vasc Surg. 2010;52:103\u20139. https:\/\/doi.org\/10.1016\/j.jvs.2010.01.088.","journal-title":"J Vasc Surg"},{"key":"1654_CR299","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1291\/hypres.30.541","volume":"30","author":"M Naya","year":"2007","unstructured":"Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res. 2007;30:541\u20138. https:\/\/doi.org\/10.1291\/hypres.30.541.","journal-title":"Hypertens Res"},{"key":"1654_CR300","doi-asserted-by":"publisher","first-page":"109721","DOI":"10.1016\/j.exer.2023.109721","volume":"237","author":"JM Hoffman","year":"2023","unstructured":"Hoffman JM, Robinson R, Greenway G, Glass J, Budkin S, Sharma S. Blockade of interleukin-6 trans-signaling prevents mitochondrial dysfunction and cellular senescence in retinal endothelial cells. Exp Eye Res. 2023;237:109721. https:\/\/doi.org\/10.1016\/j.exer.2023.109721.","journal-title":"Exp Eye Res"},{"key":"1654_CR301","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2337\/dc06-1793","volume":"30","author":"E Esteve","year":"2007","unstructured":"Esteve E, Castro A, Lopez-Bermejo A, Vendrell J, Ricart W, Fernandez-Real JM. Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity. Diabetes Care. 2007;30:939\u201345. https:\/\/doi.org\/10.2337\/dc06-1793.","journal-title":"Diabetes Care"},{"key":"1654_CR302","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000094588","volume":"107","author":"B Erzen","year":"2007","unstructured":"Erzen B, Sabovic M, Sebestjen M, Keber I, Poredos P. Interleukin-6 correlates with endothelial dysfunction in young post-myocardial infarction patients. Cardiology. 2007;107:111\u20136. https:\/\/doi.org\/10.1159\/000094588.","journal-title":"Cardiology"},{"key":"1654_CR303","first-page":"114","volume":"4","author":"V Cavieres","year":"2014","unstructured":"Cavieres V, Valdes K, Moreno B, Moore-Carrasco R, Gonzalez DR. Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6. Am J Cardiovasc Dis. 2014;4:114\u201322.","journal-title":"Am J Cardiovasc Dis"},{"key":"1654_CR304","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1161\/01.cir.96.9.3042","volume":"96","author":"K Bhagat","year":"1997","unstructured":"Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation. 1997;96:3042\u20137. https:\/\/doi.org\/10.1161\/01.cir.96.9.3042.","journal-title":"Circulation"},{"key":"1654_CR305","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1161\/atvbaha.107.153080","volume":"27","author":"LI Schrader","year":"2007","unstructured":"Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol. 2007;27:2576\u201381. https:\/\/doi.org\/10.1161\/atvbaha.107.153080.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1654_CR306","doi-asserted-by":"publisher","first-page":"510243","DOI":"10.1155\/2013\/510243","volume":"2013","author":"PH Dessein","year":"2013","unstructured":"Dessein PH, Solomon A, Woodiwiss AJ, Norton GR, Tsang L, Gonzalez-Gay MA. Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis. Mediators Inflamm. 2013;2013:510243. https:\/\/doi.org\/10.1155\/2013\/510243.","journal-title":"Mediators Inflamm"},{"key":"1654_CR307","first-page":"161","volume":"24","author":"PH Dessein","year":"2006","unstructured":"Dessein PH, Joffe BI. Suppression of circulating interleukin-6 concentrations is associated with decreased endothelial activation in rheumatoid arthritis. Clin Exp Rheumatol. 2006;24:161\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"1654_CR308","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2010.133587","volume":"70","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, Spiller DG, Anderson ME, Edwards SW, Moots RJ. Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis. 2011;70:366\u201372. https:\/\/doi.org\/10.1136\/ard.2010.133587.","journal-title":"Ann Rheum Dis"},{"key":"1654_CR309","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00296-015-3314-1","volume":"35","author":"F Genre","year":"2015","unstructured":"Genre F, Lopez-Mejias R, Miranda-Filloy JA, Ubilla B, Mijares V, Carnero-Lopez B, Gomez-Acebo I, Dierssen-Sotos T, Remuzgo-Martinez S, Blanco R, Pina T, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Anti-TNF-alpha therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients. Rheumatol Int. 2015;35:2069\u201378. https:\/\/doi.org\/10.1007\/s00296-015-3314-1.","journal-title":"Rheumatol Int"},{"key":"1654_CR310","doi-asserted-by":"publisher","unstructured":"Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Huffman JW, Csiszar A, Ungvari ZI, Mackie K, Chatterjee S, Pacher P. Cannabinoid-2 receptor stimulation attenuates TNF{alpha}-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am J Physiol Heart Circ Physiol. 2007. https:\/\/doi.org\/10.1152\/ajpheart.00688.2007","DOI":"10.1152\/ajpheart.00688.2007"},{"key":"1654_CR311","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1152\/japplphysiol.90470.2008","volume":"105","author":"A Csiszar","year":"2008","unstructured":"Csiszar A, Wang M, Lakatta EG, Ungvari ZI. Inflammation and endothelial dysfunction during aging: role of NF-{kappa}B. J Appl Physiol. 2008;105:1333\u201341. https:\/\/doi.org\/10.1152\/japplphysiol.90470.2008.","journal-title":"J Appl Physiol"},{"key":"1654_CR312","first-page":"H1694","volume":"291","author":"A Csiszar","year":"2006","unstructured":"Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: role of NF-{kappa}B inhibition. Am J Physiol. 2006;291:H1694-1699.","journal-title":"Am J Physiol"},{"key":"1654_CR313","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1212\/WNL.0b013e318248e50f","volume":"78","author":"CL Satizabal","year":"2012","unstructured":"Satizabal CL, Zhu YC, Mazoyer B, Dufouil C, Tzourio C. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology. 2012;78:720\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318248e50f.","journal-title":"Neurology"},{"key":"1654_CR314","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/STROKEAHA.107.508135","volume":"39","author":"M Fornage","year":"2008","unstructured":"Fornage M, Chiang YA, O\u2019Meara ES, Psaty BM, Reiner AP, Siscovick DS, Tracy RP, Longstreth WT. Biomarkers of inflammation and MRI-defined small vessel disease of the brain. Stroke. 2008;39:1952\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.107.508135.","journal-title":"Stroke"},{"key":"1654_CR315","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12877-015-0063-7","volume":"15","author":"AE Tchalla","year":"2015","unstructured":"Tchalla AE, Wellenius GA, Sorond FA, Travison TG, Dantoine T, Lipsitz LA. Elevated circulating vascular cell adhesion molecule-1 (sVCAM-1) is associated with concurrent depressive symptoms and cerebral white matter Hyperintensities in older adults. BMC Geriatr. 2015;15:62. https:\/\/doi.org\/10.1186\/s12877-015-0063-7.","journal-title":"BMC Geriatr"},{"key":"1654_CR316","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12974-016-0495-9","volume":"13","author":"K Kangwantas","year":"2016","unstructured":"Kangwantas K, Pinteaux E, Penny J. The extracellular matrix protein laminin-10 promotes blood-brain barrier repair after hypoxia and inflammation in vitro. J Neuroinflammation. 2016;13:25. https:\/\/doi.org\/10.1186\/s12974-016-0495-9.","journal-title":"J Neuroinflammation"},{"key":"1654_CR317","doi-asserted-by":"publisher","first-page":"e101815","DOI":"10.1371\/journal.pone.0101815","volume":"9","author":"KD Rochfort","year":"2014","unstructured":"Rochfort KD, Collins LE, Murphy RP, Cummins PM. Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One. 2014;9:e101815. https:\/\/doi.org\/10.1371\/journal.pone.0101815.","journal-title":"PLoS One"},{"key":"1654_CR318","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/156720210793180800","volume":"7","author":"P Thornton","year":"2010","unstructured":"Thornton P, McColl BW, Cooper L, Rothwell NJ, Allan SM. Interleukin-1 drives cerebrovascular inflammation via MAP kinase-independent pathways. Curr Neurovasc Res. 2010;7:330\u201340. https:\/\/doi.org\/10.2174\/156720210793180800.","journal-title":"Curr Neurovasc Res"},{"key":"1654_CR319","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.7150\/thno.68304","volume":"12","author":"V Rajeev","year":"2022","unstructured":"Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Lai MKP, Chen CL, Drummond GR, Sobey CG, Arumugam TV. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics. 2022;12:1639\u201358. https:\/\/doi.org\/10.7150\/thno.68304.","journal-title":"Theranostics"},{"key":"1654_CR320","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jneuroim.2008.09.007","volume":"205","author":"RA Linker","year":"2008","unstructured":"Linker RA, Luhder F, Kallen KJ, Lee DH, Engelhardt B, Rose-John S, Gold R. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. J Neuroimmunol. 2008;205:64\u201372. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.09.007.","journal-title":"J Neuroimmunol"},{"key":"1654_CR321","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/brainsci10100679","volume":"10","author":"D Furutama","year":"2020","unstructured":"Furutama D, Matsuda S, Yamawaki Y, Hatano S, Okanobu A, Memida T, Oue H, Fujita T, Ouhara K, Kajiya M, Mizuno N, Kanematsu T, Tsuga K, Kurihara H. IL-6 induced by periodontal inflammation causes neuroinflammation and disrupts the blood-brain barrier. Brain Sci. 2020;10:679. https:\/\/doi.org\/10.3390\/brainsci10100679.","journal-title":"Brain Sci"},{"key":"1654_CR322","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0304-3940(98)00060-3","volume":"242","author":"G Farkas","year":"1998","unstructured":"Farkas G, Marton J, Nagy Z, Mandi Y, Takacs T, Deli MA, Abraham CS. Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6. Neurosci Lett. 1998;242:147\u201350. https:\/\/doi.org\/10.1016\/s0304-3940(98)00060-3.","journal-title":"Neurosci Lett"},{"key":"1654_CR323","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/00005072-199511000-00003","volume":"54","author":"FM Brett","year":"1995","unstructured":"Brett FM, Mizisin AP, Powell HC, Campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol. 1995;54:766\u201375. https:\/\/doi.org\/10.1097\/00005072-199511000-00003.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 3","key":"1654_CR324","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/brain\/120.3.435","volume":"120","author":"DC Anthony","year":"1997","unstructured":"Anthony DC, Bolton SJ, Fearn S, Perry VH. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain. 1997;120(Pt 3):435\u201344. https:\/\/doi.org\/10.1093\/brain\/120.3.435.","journal-title":"Brain"},{"key":"1654_CR325","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63438-4","volume":"165","author":"CC Ferrari","year":"2004","unstructured":"Ferrari CC, Depino AM, Prada F, Muraro N, Campbell S, Podhajcer O, Perry VH, Anthony DC, Pitossi FJ. Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol. 2004;165:1827\u201337. https:\/\/doi.org\/10.1016\/S0002-9440(10)63438-4.","journal-title":"Am J Pathol"},{"key":"1654_CR326","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00004647-199703000-00005","volume":"17","author":"T Kossmann","year":"1997","unstructured":"Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab. 1997;17:280\u20139. https:\/\/doi.org\/10.1097\/00004647-199703000-00005.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1654_CR327","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000350470","volume":"20","author":"SS Cohen","year":"2013","unstructured":"Cohen SS, Min M, Cummings EE, Chen X, Sadowska GB, Sharma S, Stonestreet BS. Effects of interleukin-6 on the expression of tight junction proteins in isolated cerebral microvessels from yearling and adult sheep. NeuroImmunoModulation. 2013;20:264\u201373. https:\/\/doi.org\/10.1159\/000350470.","journal-title":"NeuroImmunoModulation"},{"key":"1654_CR328","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1742-2094-2-15","volume":"2","author":"JM Craft","year":"2005","unstructured":"Craft JM, Watterson DM, Hirsch E, Van Eldik LJ. Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid. J Neuroinflammation. 2005;2:15. https:\/\/doi.org\/10.1186\/1742-2094-2-15.","journal-title":"J Neuroinflammation"},{"key":"1654_CR329","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.jcbfm.9600002","volume":"25","author":"A Basu","year":"2005","unstructured":"Basu A, Lazovic J, Krady JK, Mauger DT, Rothstein RP, Smith MB, Levison SW. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic\/ischemic injury. J Cereb Blood Flow Metab. 2005;25:17\u201329. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600002.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1654_CR330","doi-asserted-by":"publisher","first-page":"e84269","DOI":"10.1371\/journal.pone.0084269","volume":"8","author":"C van Kralingen","year":"2013","unstructured":"van Kralingen C, Kho DT, Costa J, Angel CE, Graham ES. Exposure to inflammatory cytokines IL-1\u03b2 and TNF\u03b1 induces compromise and death of astrocytes; implications for chronic neuroinflammation. PLoS One. 2013;8:e84269. https:\/\/doi.org\/10.1371\/journal.pone.0084269.","journal-title":"PLoS One"},{"key":"1654_CR331","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2019.09.017","volume":"85","author":"WM Freeze","year":"2020","unstructured":"Freeze WM, Jacobs HIL, de Jong JJ, Verheggen ICM, Gronenschild E, Palm WM, Hoff EI, Wardlaw JM, Jansen JFA, Verhey FR, Backes WH. White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed. Neurobiol Aging. 2020;85:113\u201322. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.09.017.","journal-title":"Neurobiol Aging"},{"key":"1654_CR332","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1161\/STROKEAHA.115.009589","volume":"46","author":"BN Huisa","year":"2015","unstructured":"Huisa BN, Caprihan A, Thompson J, Prestopnik J, Qualls CR, Rosenberg GA. Long-term blood-brain barrier permeability changes in Binswanger disease. Stroke. 2015;46:2413\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009589.","journal-title":"Stroke"},{"key":"1654_CR333","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/bj2630539","volume":"263","author":"B Meier","year":"1989","unstructured":"Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J. 1989;263:539\u201345. https:\/\/doi.org\/10.1042\/bj2630539.","journal-title":"Biochem J"},{"key":"1654_CR334","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1128\/mcb.16.12.7115","volume":"16","author":"DJ Sulciner","year":"1996","unstructured":"Sulciner DJ, Irani K, Yu ZX, Ferrans VJ, Goldschmidt-Clermont P, Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol. 1996;16:7115\u201321. https:\/\/doi.org\/10.1128\/mcb.16.12.7115.","journal-title":"Mol Cell Biol"},{"key":"1654_CR335","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1089\/ars.2011.3923","volume":"15","author":"C Lehner","year":"2011","unstructured":"Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, Bauer H. Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal. 2011;15:1305\u201323. https:\/\/doi.org\/10.1089\/ars.2011.3923.","journal-title":"Antioxid Redox Signal"},{"issue":"105","key":"1654_CR336","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1152\/japplphysiol.90470.2008","volume":"2008","author":"A Csiszar","year":"1985","unstructured":"Csiszar A, Wang M, Lakatta EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol. 1985;2008(105):1333\u201341. https:\/\/doi.org\/10.1152\/japplphysiol.90470.2008.","journal-title":"J Appl Physiol"},{"key":"1654_CR337","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1471-4159.2006.04393.x","volume":"101","author":"J Haorah","year":"2007","unstructured":"Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, Persidsky Y. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem. 2007;101:566\u201376. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04393.x.","journal-title":"J Neurochem"},{"key":"1654_CR338","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697\u2013709. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1654_CR339","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12974-017-0908-4","volume":"14","author":"SM Krasnow","year":"2017","unstructured":"Krasnow SM, Knoll JG, Verghese SC, Levasseur PR, Marks DL. Amplification and propagation of interleukin-1\u03b2 signaling by murine brain endothelial and glial cells. J Neuroinflammation. 2017;14:133. https:\/\/doi.org\/10.1186\/s12974-017-0908-4.","journal-title":"J Neuroinflammation"},{"key":"1654_CR340","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","volume":"103","author":"C Zhang","year":"2008","unstructured":"Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103:398\u2013406. https:\/\/doi.org\/10.1007\/s00395-008-0733-0.","journal-title":"Basic Res Cardiol"},{"key":"1654_CR341","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2967\/jnumed.118.225169","volume":"60","author":"LA Perkins","year":"2019","unstructured":"Perkins LA, Anderson CJ, Novelli EM. Targeting P-selectin adhesion molecule in molecular imaging: P-selectin expression as a valuable imaging biomarker of inflammation in cardiovascular disease. J Nucl Med. 2019;60:1691\u20137. https:\/\/doi.org\/10.2967\/jnumed.118.225169.","journal-title":"J Nucl Med"},{"key":"1654_CR342","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1530\/vb-19-0033","volume":"2","author":"L Marchetti","year":"2020","unstructured":"Marchetti L, Engelhardt B. Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation. Vasc Biol. 2020;2:H1-h18. https:\/\/doi.org\/10.1530\/vb-19-0033.","journal-title":"Vasc Biol"},{"key":"1654_CR343","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1002\/1521-4141(200212)32:12<3598::Aid-immu3598>3.0.Co;2-6","volume":"32","author":"M Laschinger","year":"2002","unstructured":"Laschinger M, Vajkoczy P, Engelhardt B. Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur J Immunol. 2002;32:3598\u2013606. https:\/\/doi.org\/10.1002\/1521-4141(200212)32:12%3c3598::Aid-immu3598%3e3.0.Co;2-6.","journal-title":"Eur J Immunol"},{"key":"1654_CR344","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s10753-015-0298-7","volume":"39","author":"Y Sun","year":"2016","unstructured":"Sun Y, Li N, Zhang J, Liu H, Liu J, Xia X, Sun C, Feng X, Gu J, Du C, Han W, Lei L. Enolase of Streptococcus Suis Serotype 2 enhances blood-brain barrier permeability by inducing IL-8 release. Inflammation. 2016;39:718\u201326. https:\/\/doi.org\/10.1007\/s10753-015-0298-7.","journal-title":"Inflammation"},{"key":"1654_CR345","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/jsre.2002.6415","volume":"104","author":"TR Desai","year":"2002","unstructured":"Desai TR, Leeper NJ, Hynes KL, Gewertz BL. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res. 2002;104:118\u201323. https:\/\/doi.org\/10.1006\/jsre.2002.6415.","journal-title":"J Surg Res"},{"key":"1654_CR346","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41583-019-0201-x","volume":"20","author":"K Kierdorf","year":"2019","unstructured":"Kierdorf K, Masuda T, Jord\u00e3o MJC, Prinz M. Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat Rev Neurosci. 2019;20:547\u201362. https:\/\/doi.org\/10.1038\/s41583-019-0201-x.","journal-title":"Nat Rev Neurosci"},{"key":"1654_CR347","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP, Lelios I, Heppner FL, Kipnis J, Merkler D, Greter M, Becher B. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48:380-395.e386. https:\/\/doi.org\/10.1016\/j.immuni.2018.01.011.","journal-title":"Immunity"},{"key":"1654_CR348","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.expneurol.2003.11.005","volume":"186","author":"DC Hess","year":"2004","unstructured":"Hess DC, Abe T, Hill WD, Studdard AM, Carothers J, Masuya M, Fleming PA, Drake CJ, Ogawa M. Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol. 2004;186:134\u201344. https:\/\/doi.org\/10.1016\/j.expneurol.2003.11.005.","journal-title":"Exp Neurol"},{"key":"1654_CR349","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/glia.440070106","volume":"7","author":"H Lassmann","year":"1993","unstructured":"Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia. 1993;7:19\u201324. https:\/\/doi.org\/10.1002\/glia.440070106.","journal-title":"Glia"},{"key":"1654_CR350","doi-asserted-by":"publisher","first-page":"281","DOI":"10.14348\/molcells.2021.0060","volume":"44","author":"E Lee","year":"2021","unstructured":"Lee E, Eo JC, Lee C, Yu JW. Distinct features of brain-resident macrophages: microglia and non-parenchymal brain macrophages. Mol Cells. 2021;44:281\u201391. https:\/\/doi.org\/10.14348\/molcells.2021.0060.","journal-title":"Mol Cells"},{"key":"1654_CR351","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-023-02397-2","volume":"29","author":"H Bouzid","year":"2023","unstructured":"Bouzid H, Belk JA, Jan M, Qi Y, Sarnowski C, Wirth S, Ma L, Chrostek MR, Ahmad H, Nachun D, Yao W, Beiser A, Bick AG, Bis JC, Fornage M, Longstreth WT Jr, Lopez OL, Natarajan P, Psaty BM, Satizabal CL, Weinstock J, Larson EB, Crane PK, Keene CD, Seshadri S, Satpathy AT, Montine TJ, Jaiswal S. Clonal hematopoiesis is associated with protection from Alzheimer\u2019s disease. Nat Med. 2023;29:1662\u201370. https:\/\/doi.org\/10.1038\/s41591-023-02397-2.","journal-title":"Nat Med"},{"key":"1654_CR352","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-01024-9","author":"J Faakye","year":"2023","unstructured":"Faakye J, Nyul-Toth A, Muranyi M, Gulej R, Csik B, Shanmugarama S, Tarantini S, Negri S, Prodan C, Mukli P, Yabluchanskiy A, Conley S, Toth P, Csiszar A, Ungvari Z. Preventing spontaneous cerebral microhemorrhages in aging mice: a novel approach targeting cellular senescence with ABT263\/navitoclax. Geroscience. 2023. https:\/\/doi.org\/10.1007\/s11357-023-01024-9.","journal-title":"Geroscience"},{"key":"1654_CR353","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11357-018-0044-9","volume":"40","author":"Z Ungvari","year":"2018","unstructured":"Ungvari Z, Yabluchanskiy A, Tarantini S, Toth P, Kirkpatrick AC, Csiszar A, Prodan CI. Repeated Valsalva maneuvers promote symptomatic manifestations of cerebral microhemorrhages: implications for the pathogenesis of vascular cognitive impairment in older adults. Geroscience. 2018;40:485\u201396. https:\/\/doi.org\/10.1007\/s11357-018-0044-9.","journal-title":"Geroscience"},{"key":"1654_CR354","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/acel.12315","volume":"14","author":"P Toth","year":"2015","unstructured":"Toth P, Tarantini S, Springo Z, Tucsek Z, Gautam T, Giles CB, Wren JD, Koller A, Sonntag WE, Csiszar A, Ungvari Z. Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell. 2015;14:400\u20138. https:\/\/doi.org\/10.1111\/acel.12315.","journal-title":"Aging Cell"},{"key":"1654_CR355","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acel.12583","volume":"16","author":"S Tarantini","year":"2017","unstructured":"Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Springo Z, Fulop GA, Ashpole N, Gautam T, Giles CB, Wren JD, Sonntag WE, Csiszar A, Ungvari Z. Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype. Aging Cell. 2017;16:469\u201379. https:\/\/doi.org\/10.1111\/acel.12583.","journal-title":"Aging Cell"},{"key":"1654_CR356","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"key":"1654_CR357","doi-asserted-by":"publisher","first-page":"105575","DOI":"10.1016\/j.intimp.2019.04.022","volume":"74","author":"R Gao","year":"2019","unstructured":"Gao R, Shi H, Chang S, Gao Y, Li X, Lv C, Yang H, Xiang H, Yang J, Xu L, Tang Y. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction. Int Immunopharmacol. 2019;74:105575. https:\/\/doi.org\/10.1016\/j.intimp.2019.04.022.","journal-title":"Int Immunopharmacol"},{"key":"1654_CR358","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3324\/haematol.2022.281705","volume":"108","author":"G Carra","year":"2023","unstructured":"Carra G, Giugliano E, Camerlo S, Rosati G, Branca E, Maffeo B, Russo I, Piazza R, Cilloni D, Morotti A. Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis. Haematologica. 2023;108:1447\u20139. https:\/\/doi.org\/10.3324\/haematol.2022.281705.","journal-title":"Haematologica"},{"key":"1654_CR359","doi-asserted-by":"publisher","first-page":"132284","DOI":"10.1016\/j.ijcard.2024.132284","volume":"411","author":"A Bonaventura","year":"2024","unstructured":"Bonaventura A, Liberale L. Clonal hematopoiesis, NETosis and arterial thrombosis: a deadly combination. Int J Cardiol. 2024;411:132284. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132284.","journal-title":"Int J Cardiol"}],"updated-by":[{"DOI":"10.1007\/s11357-026-02210-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000}}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01654-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01654-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01654-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:36:25Z","timestamp":1773894985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01654-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":359,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01654-1","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11357-026-02210-1","URL":"https:\/\/doi.org\/10.1007\/s11357-026-02210-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Hajnalka Andrikovics, Dr. Farzaneh Sorond, Dr. Andriy Yabluchanskiy, and Dr. Stefano Tarantini serve as Associate Editors for GeroScience. Dr. Zoltan Ungvari serves as Editor-in-Chief for GeroScience and has personal relationships with individuals involved in the submission of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}